{
  "dataset": "GLP-1 Dossier — US GLP-1 Telehealth Provider Record",
  "version": "v34.8",
  "updatedAt": "2026-11-16",
  "license": "CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/)",
  "attribution": "Cite GLP-1 Dossier (https://glp1dossier.com)",
  "sourceUrl": "https://glp1dossier.com",
  "counts": {
    "providers": 128,
    "compoundedOnly": 65,
    "bothCompoundedAndBranded": 44,
    "brandedOnly": 19,
    "flaggedProviders": 78,
    "regulatoryActions": 88,
    "primarySourcedActions": 88,
    "otherSignals": 13
  },
  "providers": [
    {
      "id": "24hrdoc",
      "name": "24hrdoc",
      "dossierUrl": "https://glp1dossier.com/is-24hrdoc-legit",
      "providerUrl": "https://www.24hrdoc.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Oral Semaglutide",
        "Compounded Tirzepatide",
        "Microdose Tirzepatide"
      ],
      "oralOffered": true,
      "priceFromUsd": 129,
      "promoPriceUsd": 110,
      "medicationIncluded": null,
      "feeStructure": "unspecified",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No monthly membership fee advertised; general urgent-care telehealth consultations are priced separately from $39.99 (per 24hrdoc.com/medications and 24hrdoc.com/refund-policy, refunds are issued only if cancelled prior to medical provider review or if treatment is not recommended)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to 24HrDoc, Inc. alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the 24HrDoc name, representing it as the manufacturer when it was not, and because website claims such as \"Same ingredients as: Ozempic and Wegovy\" implied the products were FDA-approved.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/24hrdoc-inc-dba-24hrdoc-717984-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by 24HrDoc, Inc. / 24hrdoc LLC (www.24hrdoc.com; 3050 Post Oak Blvd, Houston, TX 77056). Following the 20 February 2026 FDA Warning Letter (No. 717984) over its compounded semaglutide and tirzepatide product pages, 24hrdoc.com removed its standalone /semaglutide and /tirzepatide URLs (now returning 404), and 24hrdoc.com/medications states: '24hrdoc is not a pharmacy. We do not carry or ship medicines. Online Doctor Prescriptions are sent electronically to your pharmacy after an online medical consultation.' Whether medication was included in its previously advertised $129/month ($110 first-month promo) weight-loss figure is unclear because the site FAQ states consultation fees do not include medication costs."
    },
    {
      "id": "agelessrx",
      "name": "AgelessRx",
      "dossierUrl": "https://glp1dossier.com/is-agelessrx-legit",
      "providerUrl": "https://agelessrx.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Microdosed compounded semaglutide",
        "Microdosed compounded tirzepatide",
        "Compounded semaglutide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee advertised. Prices are subscription rates and the lower tiers require prepayment — microdosed tirzepatide at $159 a month applies to a four-month plan billed in full.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "AgelessRx filed a notice with the California Attorney General reporting that between 17 and 22 April 2026 an unauthorised party accessed help-desk tickets containing customer names together with date of birth, health diagnosis or condition, medications and other treatment information, and offered twelve months of Experian credit monitoring in response. This is a breach the company disclosed about itself, not an enforcement action against it.",
          "source": "https://oag.ca.gov/system/files/AgelessRx%20-%20Notice%20of%20Data%20Event%20-%20CA_0.pdf",
          "date": "2026-05",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Microdosed semaglutide starts at $99 a month and microdosed tirzepatide at $159 on a four-month prepaid plan. A brief video consultation may be required depending on the state; otherwise intake is asynchronous."
    },
    {
      "id": "alan",
      "name": "Alan",
      "dossierUrl": "https://glp1dossier.com/is-alan-legit",
      "providerUrl": "https://www.alanmeds.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide+",
        "Compounded Tirzepatide",
        "Oral Compounded GLP-1",
        "Microdosing Compounded Semaglutide+",
        "Microdosing Compounded Tirzepatide+",
        "Wegovy",
        "Zepbound",
        "Ozempic",
        "Mounjaro"
      ],
      "oralOffered": true,
      "priceFromUsd": 125,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership or consultation fee, but several plans require a multi-month commitment — compounded semaglutide is $158/mo on a two-month minimum and microdosed tirzepatide $145/mo on six-month plans",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Alan Health Technologies Inc. alleging it misbranded compounded semaglutide and tirzepatide, stating that the representations on its website that Alan is the compounder of these drug products are false or misleading, and that the products appear not to meet the conditions for compounded-drug exemptions under sections 503A or 503B.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alan-health-technologies-inc-dba-alan-721814-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Now lists branded medication alongside its compounded line — Wegovy $1,695, Zepbound $1,385, Ozempic $1,315, Mounjaro $1,395 — while compounded options run $125-$325/mo. The compounded catalogue described in the February 2026 letter is still on sale."
    },
    {
      "id": "alloy",
      "name": "Alloy",
      "dossierUrl": "https://glp1dossier.com/is-alloy-legit",
      "providerUrl": "https://www.myalloy.com/weight",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Compounded Liraglutide",
        "Wegovy",
        "Zepbound",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": 169,
      "promoPriceUsd": 119,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Curexa Pharmacy"
      ],
      "membershipFee": "$99/month mandatory Alloy Weight Care membership ($49 first month with code STARTGLP1) plus medication billed separately starting at $70/month for compounded semaglutide ($169/month combined ongoing floor) or $299/month for branded Zepbound ($398/month combined)",
      "insurance": "Cash-pay for Alloy Weight Care membership and compounded GLP-1s (HSA/FSA accepted); branded Zepbound, Wegovy, and Foundayo available cash-pay",
      "intake": "Asynchronous medical review and ongoing physician messaging with quarterly check-ins and nutrition coaching",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Operated by Alloy Health, Inc. (Alloy, Inc. per myalloy.com/terms-of-use; 307 West 38th Street, Suite 1401, New York, NY 10018), with pharmacy fulfillment disclosed through Curexa Pharmacy (1009 Tilton Rd, Egg Harbor Township, NJ). Alloy Weight Care combines a mandatory $99/month membership ($50 off first month with code STARTGLP1) with compounded semaglutide starting at $70/month ($169/month all-in ongoing), compounded tirzepatide, compounded liraglutide, or branded Zepbound, Wegovy, and oral Foundayo starting at $299/month plus membership. No FDA warning letter or federal enforcement action naming Alloy Health, Inc. was found on record."
    },
    {
      "id": "altru-telehealth",
      "name": "Altru Telehealth",
      "dossierUrl": "https://glp1dossier.com/is-altru-telehealth-legit",
      "providerUrl": "https://www.altrutelehealth.com/services",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 289,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; $289/month for the standard dose, plus $150/month for doses up to 2 mg/week",
      "insurance": "cash",
      "intake": "labs",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Altru Telehealth, LLC alleging its website described compounded semaglutide and tirzepatide as having \"FDA-approved active ingredients\" and offering \"the same results\" as branded drugs, and described compounding pharmacies as \"FDA approved\" and \"FDA licensed\", which misbranded the products.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Weight loss is one line of a broader self-pay urgent-care telehealth practice. Intake requires a history form, bloodwork, a video visit and follow-up labs every six months."
    },
    {
      "id": "altrx",
      "name": "altRx",
      "dossierUrl": "https://glp1dossier.com/is-altrx-legit",
      "providerUrl": "https://www.altrx.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Zepbound",
        "Wegovy",
        "Ozempic"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": 89,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the price covers consultation, care plan, prescription fulfilment and shipping",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Trinity HealthCare Supply, LLC dba altRx alleging its website labelling identified \"altRx\" on pictured compounded semaglutide and tirzepatide labels, suggesting altRx was the compounder when it was not, and that claims such as \"clinically proven weight loss\" represented the compounded products as FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Promotional pricing cuts compounded semaglutide from $199/mo to $89/mo and tirzepatide from $299/mo to $149/mo. Branded options are far higher: Ozempic from $1,149/mo, Zepbound from $1,249/mo, Wegovy from $1,579/mo."
    },
    {
      "id": "am-rx",
      "name": "AM Rx",
      "dossierUrl": "https://glp1dossier.com/is-am-rx-legit",
      "providerUrl": "https://getamrx.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Ozempic",
        "Wegovy",
        "Zepbound",
        "Mounjaro",
        "Semaglutide"
      ],
      "oralOffered": false,
      "priceFromUsd": 151,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the $151/month compounded semaglutide rate requires buying quarterly. Branded GLP-1s are advertised as low as $25/month for patients whose insurance covers them",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to FitRX, LLC dba AM RX alleging its compounded product labels bore \"AM Rx\" as though it were the manufacturer, and that describing the compounded drugs as containing \"the active ingredient in FDA-approved medications like Wegovy and Ozempic\" misrepresented them as FDA-approved.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "AM Rx is one of several consumer brands operated by FitRX, LLC, alongside FitRx and Zealthy. The advertised $25/month figure depends on insurance coverage, not on the cash price."
    },
    {
      "id": "amble",
      "name": "Amble Health",
      "dossierUrl": "https://glp1dossier.com/is-amble-legit",
      "providerUrl": "https://joinamble.com/glp-1-injections",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 179,
      "promoPriceUsd": 135,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Strive Pharmacy",
        "Empower Pharmacy",
        "Hallandale Pharmacy",
        "Revive Rx",
        "TX Performance Meds"
      ],
      "membershipFee": "No separate membership fee; flat-dose compounded semaglutide is $179/month on a 1-month plan, $160/month on a 3-month plan, $145/month on a 6-month plan, or $135/month on a 12-month plan; compounded tirzepatide starts at $289/month (bulk 3-, 6- and 12-month plans are billed upfront)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating F, not accredited, with a Pattern of Complaints alert, 185 unanswered complaints and 11 unresolved; themes are refunds, payment problems and non-delivery.",
          "source": "https://www.bbb.org/us/tx/houston/profile/weight-loss/amble-health-0915-90072116",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Amble Health (joinamble.com; Ambel) offers all-in compounded semaglutide ($179/month) and compounded tirzepatide ($289–$329/month) with no separate membership fee. Uses the Bask Health telehealth infrastructure and fulfills prescriptions through state-licensed 503A/503B compounding pharmacies including Revive Rx, TX Performance Meds, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, and Strive Pharmacy."
    },
    {
      "id": "amie",
      "name": "Amie",
      "dossierUrl": "https://glp1dossier.com/is-amie-legit",
      "providerUrl": "https://landers.tryamie.com/zepbound/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Zepbound (tirzepatide)",
        "Tirzepatide",
        "Semaglutide"
      ],
      "oralOffered": false,
      "priceFromUsd": 151,
      "promoPriceUsd": 39,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; compounded tirzepatide is advertised as low as $216/month when purchased quarterly",
      "insurance": "both",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Amie Health, Inc. dba Amie alleging its website made false or misleading claims about compounded semaglutide and tirzepatide, including \"All our treatments use FDA-approved active ingredients\", and that product labels displaying \"amie\" suggested Amie was the compounder when it was not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amie-health-inc-dba-amie-728276-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Advertises branded Zepbound from $39 to start and as low as $25/month with insurance; Medicare, Medicaid and TRICARE members are ineligible. The main tryamie.com homepage now leads with a sexual-health product, with the GLP-1 offering on separate landing pages."
    },
    {
      "id": "belle",
      "name": "Belle",
      "dossierUrl": "https://glp1dossier.com/is-belle-legit",
      "providerUrl": "https://www.joinbelle.com/lp/tirz-special?belle_offer=tirz_special",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Tirzepatide Microdose"
      ],
      "oralOffered": false,
      "priceFromUsd": 93,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "The Pharmacy Hub",
        "Revive Rx",
        "BPI Labs",
        "VitalRx Pharmacy",
        "Olympia Pharmaceuticals",
        "Hillstone Pharmacy",
        "OptioRx"
      ],
      "membershipFee": "No separate membership fee; one price at every dose. Read 11 Nov 2026 on Belle's product pages: compounded semaglutide $93/mo on a 12-month supply, $109/mo on 6 months, $119/mo on 2 months, $199 for one month; compounded tirzepatide $179/mo on 12 months, $189/mo on 6, $219/mo on 2, $249 for one month. Belle's tirzepatide plan page (joinbelle.com/lp/tirz-special) offers $149/mo on a 12-month plan or $179/mo on a 6-month plan, payable monthly with 0% APR financing subject to eligibility and approval; compounded tirzepatide microdose $99/mo (2-month supply). Card charged when the order is placed; a placed order cannot be cancelled or refunded, but the plan can be cancelled to stop future renewals; full refund if the prescription is not approved",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Belle Health LLC alleging it misbranded compounded semaglutide and tirzepatide because, in the letter's words, the products displayed on its website identify \"Belle\" on the pictured label, suggesting Belle is the compounder of those drugs when in fact it is not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Belle Health (joinbelle.com; operated by Belle Health, LLC, 12244 S Business Park Dr, Draper, UT 84020 per joinbelle.com/terms, last updated July 2025) is a cash-pay telehealth practice whose own clinicians prescribe flat-price compounded semaglutide and tirzepatide in all 50 states and Washington, D.C. (adults 18+). Belle's pharmacy partners page, read 11 Nov 2026, lists Hillstone Pharmacy (Knoxville, TN; 503A; semaglutide and tirzepatide), BPI Labs (Largo, FL; FDA-registered 503B outsourcing facility; tirzepatide), OptioRx (Palm Beach Gardens, FL; 503A; semaglutide and tirzepatide) and ReviveRX (Houston, TX; 503A; semaglutide and tirzepatide), plus The Pharmacy Hub and Olympia Pharmaceuticals for non-GLP-1 products; its Terms of Service still list BPI Labs, VitalRx Pharmacy (Pearland, TX), The Pharmacy Hub and Olympia Pharmaceuticals. Belle's terms say prescription and compounded products are not returnable or refundable once shipped (incorrect or defective product: contact within 7 days) and are governed by Utah law, with disputes in Salt Lake County courts."
    },
    {
      "id": "bioverse",
      "name": "Bioverse",
      "dossierUrl": "https://glp1dossier.com/is-bioverse-legit",
      "providerUrl": "https://try.gobioverse.com/semaglutide/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Ozempic",
        "Wegovy",
        "Mounjaro",
        "Metformin"
      ],
      "oralOffered": false,
      "priceFromUsd": 129,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Tailor Made Compounding",
        "GoGoMeds"
      ],
      "membershipFee": "No membership fees; the $129/mo compounded semaglutide rate requires a six-month plan paid upfront in full",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Bioverse, Inc. alleging claims that its compounded products contained \"the same active ingredient as Ozempic and Wegovy\" or \"Mounjaro and Zepbound\" implied they were the same as FDA-approved products, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bioverse-inc-dba-bioverse-716508-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "BIOVERSE (gobioverse.com; operated alongside Curex) advertises compounded semaglutide from $139/month on multi-month prepay ($199–$239/month month-to-month) and compounded tirzepatide from $229/month ($319/month month-to-month), plus branded Wegovy and Zepbound prescriptions. Partner pharmacies include GoGoMeds and Tailor Made Compounding."
    },
    {
      "id": "bliv",
      "name": "Bliv",
      "dossierUrl": "https://glp1dossier.com/is-bliv-legit",
      "providerUrl": "https://www.joinbliv.com/get-a-glp-1-prescription",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 116,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Bliv Wellness LLC alleging that the compounded semaglutide and tirzepatide products shown on its website display \"Bliv\" on the pictured label, suggesting Bliv is the compounder of those drugs when in fact it is not, making the representations false or misleading and the products misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bliv-wellness-llc-dba-bliv-721479-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded semaglutide as low as $116/month and tirzepatide as low as $199/month, with no branded medication offered. A separate \"as low as $29 per month\" figure on the site is a financing option, not a medication price. Intake is explicitly asynchronous with no phone or video visit."
    },
    {
      "id": "bluefitmd",
      "name": "BluefitMD",
      "dossierUrl": "https://glp1dossier.com/is-bluefitmd-legit",
      "providerUrl": "https://www.bluefitmd.com/",
      "supplies": "compounded",
      "compoundingStatus": "no_longer_offers_glp1",
      "drugs": [],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "no",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Historical, before GLP-1 was removed: no membership fee stated; the $75/mo rate required a 12-month package and applied only to the lowest starting dose, with month-to-month running far higher (for example $425/mo at 2.25 mg semaglutide and $775/mo at 15 mg tirzepatide). Current site (read 11 Nov 2026): NAD+ from $199/mo, sermorelin $212 per 6 mL vial, vitamin injections $125–$150 per vial; its Return & Refund Policy states all sales are final",
      "insurance": "cash",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to BluefitMD alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the BluefitMD name, representing it as the compounder when it was not, and because website claims such as \"Compounded Semaglutide (the same active ingredient as Ozempic and Wegovy)\" implied the compounded products had been FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bluefitmd-721446-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "No longer offers GLP-1 on its site (as of 28 September 2026). Before that it sold compounded semaglutide and tirzepatide only. The current site states that BluefitMD does not manufacture or compound medications and that compounded medications are not FDA-approved."
    },
    {
      "id": "bmimd",
      "name": "bmiMD",
      "dossierUrl": "https://glp1dossier.com/is-bmimd-legit",
      "providerUrl": "https://www.bmimd.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Compounded semaglutide microdose",
        "Compounded tirzepatide microdose"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; on 12 Nov 2026, during an “Early Black Friday” sale (limited time, no end date shown), bmimd.com/compounded-semaglutide listed compounded semaglutide at $99/mo on a 12-month plan ($1,188 total), $109/mo on 6 months ($654), $119/mo on 3 months ($357) or $129/mo month to month, each against a $229/mo list price; bmimd.com/compounded-tirzepatide listed compounded tirzepatide at $139/mo on 12 months ($1,668), $149/mo on 6 months, $159/mo on 3 months or $179/mo month to month, against a $349/mo list price",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "Novo Nordisk A/S and Novo Nordisk Inc. sued MEDCCM, Inc. (the corporate operator of bmiMD) in the Eastern District of New York on 21 May 2025 (No. 2:25-cv-02846), asserting Lanham Act trademark infringement claims over its marketing of compounded GLP-1 products. As of mid-2026 the case remained pending before Judge Joan M. Azrack following briefing on MEDCCM's motion to dismiss; allegations unproven.",
          "source": "https://www.pacermonitor.com/public/case/58157525/Novo_Nordisk_AS_et_al_v_MEDCCM,_Inc",
          "date": "2025-05",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "Better Business Bureau profile for bmiMD (Medccm, Inc., New York, NY) carries an F rating, citing failure to respond to customer complaints regarding subscription renewals, cancellation holds and Groupon voucher redemptions.",
          "source": "https://www.bbb.org/us/ny/new-york/profile/telemedicine/bmimd-0121-87170497",
          "date": "2026-01",
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Medccm, Inc. (420 Lexington Ave, Suite 1402, New York, NY 10170). Sells compounded semaglutide and tirzepatide (including microdose plans) at flat dosing rates across all 50 states, with full refund if a clinician determines you are ineligible, a $50 administrative cancellation fee if you cancel after intake review begins, and a strict non-refundable rule on prepaid multi-month plans once the first shipment is sent to the pharmacy. Auto-renewal holds are placed five days before renewal and cancellation requires at least seven days' notice before the renewal date. Neither the medical group nor the dispensing compounding pharmacies are named on the public site prior to enrollment."
    },
    {
      "id": "bodybuilding-health-plus",
      "name": "Bodybuilding Health+",
      "dossierUrl": "https://glp1dossier.com/is-bodybuilding-health-plus-legit",
      "providerUrl": "https://bbhealthplus.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 141.5,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Strive Pharmacy",
        "Epiq Scripts",
        "Belmar Pharmacy",
        "Casa Pharma Rx"
      ],
      "membershipFee": "No membership fee. Tiered prepay read on 30 Oct 2026: compounded semaglutide $179/mo for one month, $159.33/mo on 3 months, $158/mo on 6 months and $141.50/mo on 12 months; compounded tirzepatide $209/mo for one month, $179/mo on 3 months, $174.67/mo on 6 months and $187.33/mo on 12 months, as listed on bbhealthplus.com",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The GLP-1 telehealth arm of the Bodybuilding.com brand (bbhealthplus.com), operated by Dynamo Group LLC with fulfillment through four partner pharmacies disclosed on bbhealthplus.com: Belmar Pharmacy (800-525-9473), Strive Pharmacy (855-405-5993), Epiq Scripts (833-654-3553), and Casa Pharma Rx. The advertised $139/month rate requires a 12-month prepayment; month-to-month is $179 for the first month and $279/month thereafter, while compounded tirzepatide runs $209 first month against $319/month."
    },
    {
      "id": "calibrate",
      "name": "Calibrate",
      "dossierUrl": "https://glp1dossier.com/is-calibrate-legit",
      "providerUrl": "https://www.joincalibrate.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy",
        "Ozempic",
        "Mounjaro",
        "Zepbound",
        "Foundayo"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$199/month with a required 3-month initial commitment ($597 total), monthly thereafter; HSA/FSA eligible; medication and labs are extra",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The $199 buys service only, no medication, so it is not comparable to all-inclusive prices such as Henry Meds' $179. Requires a 20-minute clinician video visit plus labs. Corporate instability only: multiple layoff rounds (24% and 18%), CEO departure and a 2023 ownership change (https://medcitynews.com/2023/10/calibrate-obesity-ozempic-weight-loss-healthcare/); no regulatory action found."
    },
    {
      "id": "clover-meds",
      "name": "Clover Meds",
      "dossierUrl": "https://glp1dossier.com/is-clover-meds-legit",
      "providerUrl": "https://clovermeds.com/semaglutide/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 77,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; per clovermeds.com (read 11 Nov 2026) compounded semaglutide is $98 for a 1-month supply, $91/mo on 3 months ($273), $84/mo on 6 months ($504) or $77/mo on 12 months ($924), and compounded tirzepatide is $149 for one month, $141/mo on 3, $137/mo on 6 or $128/mo on 12 months ($1,536); same price on all doses",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Clover Meds LLC alleging its compounded semaglutide and tirzepatide were misbranded because the labels carried the \"Clover Meds\" name, suggesting it was the manufacturer, and because its website described products as coming from \"FDA-licensed Facilities\".",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clover-meds-llc-dba-clover-meds-728234-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Clover Meds (clovermeds.com; CloverRx) sells all-in compounded semaglutide and tirzepatide with no separate membership or consultation fee, shipped from partner 503A compounding pharmacies."
    },
    {
      "id": "cora-health",
      "name": "Cora Health",
      "dossierUrl": "https://glp1dossier.com/is-cora-health-legit",
      "providerUrl": "https://trycora.io/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; month-to-month is $175/month for compounded semaglutide and $225/month for compounded tirzepatide (same price at every dose); advertised $99/month semaglutide and $135/month tirzepatide rates require a 12-month upfront annual plan ($1,188/year or $1,620/year)",
      "insurance": "Cash-pay only (HSA/FSA accepted)",
      "intake": "Asynchronous medical intake through Wasef Health, PC",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Cora Health (trycora.io; clinical services provided through Wasef Health, PC per site footer disclosure) sells all-inclusive compounded semaglutide ($175/month month-to-month, $149/month quarterly, $125/month on 6-month plan, or $99/month on 12-month annual prepay) and compounded tirzepatide ($225/month month-to-month, $199/month quarterly, $165/month on 6-month plan, or $135/month on 12-month annual prepay) at flat pricing across all doses, fulfilled by state-licensed 503A compounding pharmacies. No FDA warning letter or federal enforcement action naming Cora Health or Wasef Health, PC was found on record."
    },
    {
      "id": "coreage-rx",
      "name": "CoreAge Rx",
      "dossierUrl": "https://glp1dossier.com/is-coreage-rx-legit",
      "providerUrl": "https://www.coreagerx.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Manifest Pharmacy"
      ],
      "membershipFee": "States there are no membership fees, no auto-rebills and no surprise charges; same price at every dose",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "CoreAge Rx (coreagerx.com; operated by DSO Fine Shrimp LLC, LegitScript certified) sells all-in flat-dose compounded semaglutide and tirzepatide with no membership fee. Dispenses through Manifest Pharmacy and state-licensed 503A compounding pharmacies."
    },
    {
      "id": "curex",
      "name": "Curex",
      "dossierUrl": "https://glp1dossier.com/is-curex-legit",
      "providerUrl": "https://getcurex.com/cl/glp",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide injection (weekly, often with vitamin B12)",
        "Compounded semaglutide sublingual tablet (daily oral drops/tablets)",
        "Compounded tirzepatide injection (weekly, often with vitamin B12)",
        "Compounded tirzepatide sublingual tablet (daily oral dissolving)"
      ],
      "oralOffered": true,
      "priceFromUsd": 199,
      "promoPriceUsd": 49,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "States a $0 membership fee and month-to-month billing with no prepay required ($49 first-month promo then $199/month for compounded semaglutide; $149 first-month promo then $299–$399/month for compounded tirzepatide; includes provider review and 1–2 day shipping)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Curex alleging its marketing of compounded semaglutide and tirzepatide — including \"clinically proven success\" and \"the same active ingredients as Ozempic or Mounjaro\" — implied its products were the same as FDA-approved drugs, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/curex-716821-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Curex, Inc. (getcurex.com; 777 Brickell Ave #500-95053, Miami, FL 33131) with clinical consultations through Curex Medical Group (Curex Medical Services P.A., Curex Medical of California P.C., and Curex Medical of New Jersey P.C., per getcurex.com/terms updated May 18, 2026). Curex weight loss supplies compounded GLP-1 medications only (no FDA-approved branded GLP-1s); Curex's original business line is sublingual allergy immunotherapy (which bills insurance), whereas the Curex GLP-1 weight-loss program is cash-pay (HSA/FSA accepted). Available across all 50 states, though California residents are limited by state regulation to oral dissolving sublingual tablets only (no compounded GLP-1 injections). Advertises a '365-Day Money-Back Guarantee' subject to program eligibility terms, plus a full refund if a clinician does not prescribe."
    },
    {
      "id": "dh-medical-services",
      "name": "D&H Medical Center",
      "dossierUrl": "https://glp1dossier.com/is-dh-medical-services-legit",
      "providerUrl": "https://www.dhmedicalcenter.com/weigthloss/glp-1",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide (Daily Capsules)",
        "Compounded Semaglutide (Weekly Injections)",
        "Compounded Tirzepatide (Weekly Injections)"
      ],
      "oralOffered": false,
      "priceFromUsd": 230,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to D&H Medical Services alleging that marketing its compounded products as the \"Same ingredient as Ozempic\", \"Same ingredient as Rybelsus\" and \"Same ingredient as Mounjaro\" represented them as FDA-approved or evaluated for safety and effectiveness when they were not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dh-medical-services-728238-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Prices are shown only as \"start from\" figures ($230 daily capsules, $299 weekly semaglutide, $399 weekly tirzepatide) and the page does not state what billing period they cover. Runs an online flow alongside two Florida clinics."
    },
    {
      "id": "directmeds",
      "name": "DirectMeds",
      "dossierUrl": "https://glp1dossier.com/is-directmeds-legit",
      "providerUrl": "https://directmeds.com/solutions/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide injection (weekly GLP-1)",
        "Compounded semaglutide oral drops (daily sublingual)",
        "Compounded tirzepatide injection (weekly GLP-1/GIP)",
        "Compounded oral tirzepatide",
        "Sermorelin",
        "Citradine",
        "SatiaLean"
      ],
      "oralOffered": true,
      "priceFromUsd": 249,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee. Read 11 Nov 2026: compounded semaglutide injections $297/month and compounded tirzepatide $399/month all-in on directmeds.com/pricing (updated 11 Aug 2026); sublingual semaglutide drops from $249/month on directmeds.com/solutions/weight-loss; 6- and 12-month bulk prices and the “from $147/month” headline product are not published. Per directmeds.com/dmo/terms (updated 16 April 2026), the subscription is charged every 30 days as 'DM2*Directmeds' unless auto-refill is turned off at least 48 hours before the next processing date, prescription orders can be cancelled only within 24 hours, and returned medications incur a $35 disposal fee",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to directmeds.com, Inc. alleging its compounded semaglutide and tirzepatide were misbranded because claims that the products \"contain the same active ingredient as branded\" medications and are an \"effective and budget-friendly alternative\" implied equivalence to FDA-approved drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/directmedscom-inc-dba-directmeds-716822-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by directmeds.com, Inc. (www.directmeds.com; Bluffdale, Utah / mailing address 1321 Upland Dr PMB 4059, Houston, TX 77043; LegitScript certified). Plans start at $249/month for daily sublingual compounded semaglutide oral drops and $297/month for weekly compounded semaglutide injections, with clinician consultation, medication, and shipping included (cash-pay model; HSA/FSA accepted). Per Section 5 and Section 15 of directmeds.com/dmo/terms (updated April 16, 2026), initial prescription orders may only be cancelled within 24 hours of placement if not yet sent to the provider network, recurring refills must be cancelled at least 48 hours before the next billing date, and prescriptions do not ship in child-resistant packaging."
    },
    {
      "id": "drmedhealth",
      "name": "DrMedHealth",
      "dossierUrl": "https://glp1dossier.com/is-drmedhealth-legit",
      "providerUrl": "https://drmedhealth.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Tirzepatide",
        "Oral Semaglutide",
        "Oral Tirzepatide"
      ],
      "oralOffered": true,
      "priceFromUsd": 199,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Public Health Solution LLC dba DrMedHealth alleging that website claims describing its compounded products as having the \"Same active ingredient as Ozempic\" and \"Same active ingredient as Mounjaro\" misrepresented compounded drugs as FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/public-health-solution-llc-dba-drmedhealth-728278-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The site states it offers both compounded and FDA-approved brand options, but only the compounded products are priced ($199/mo semaglutide, $299/mo tirzepatide); no branded drug is listed for sale."
    },
    {
      "id": "dudemeds",
      "name": "DudeMeds",
      "dossierUrl": "https://glp1dossier.com/is-dudemeds-legit",
      "providerUrl": "https://www.dudemeds.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide + vitamin B6",
        "Compounded tirzepatide + vitamin B6"
      ],
      "oralOffered": false,
      "priceFromUsd": 196,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No recurring subscription or membership fee on the weight-loss storefront: after a 28-day intro vial ($99 for semaglutide + B6 at 0.25 mg/week or $149 for tirzepatide + B6 at 2.5 mg/week), refills are sold as manual 56-day (8-week) one-time purchases of $392–$552 ($196–$276 per 4 weeks) for semaglutide and $472–$792 ($236–$396 per 4 weeks) for tirzepatide depending on dose tier.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by DudeMeds LLC (whose Terms and Conditions cite Florida incorporation while its Terms of Sale cite Delaware). Unusually for the telehealth GLP-1 market, DudeMeds sells compounded semaglutide and tirzepatide (formulated with vitamin B6) as one-time purchases with no automatic recurring billing — patients manually request 8-week refills through its TEHR portal when ready. That storefront promise conflicts with older boilerplate in its general Terms and Conditions stating that fees for the first three months of weight-loss medication are due even if treatment is terminated early. Not available in AL, AR, CA, KY or SC; dispensing pharmacies are not named publicly. No FDA warning letter or regulatory action was found on record against DudeMeds LLC."
    },
    {
      "id": "eden",
      "name": "Eden",
      "dossierUrl": "https://glp1dossier.com/is-eden-legit",
      "providerUrl": "https://www.tryeden.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "Ozempic",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": null,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Precision Compounding Pharmacy",
        "Boothwyn Pharmacy"
      ],
      "membershipFee": "Membership is referenced but the fee is not disclosed on the site",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Eden Health International, Inc. dba Eden (MARCS-CMS 728279).",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating F, not accredited, with a Pattern of Complaints alert and 109 complaints of which 84 received no response; themes are unauthorized and duplicate charges, unanswered messages and medication changed without notification.",
          "source": "https://www.bbb.org/us/co/denver/profile/weight-loss/eden-1296-1000164922",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Eden (tryeden.com; TryEden / Eden Meds, operated by Eden Health International Inc.) offers all-in compounded semaglutide injections ($296/month ongoing after $196 first-month promo), oral sublingual semaglutide drops ($246/month), and compounded tirzepatide ($396/month), fulfilled through state-licensed 503A compounding pharmacies including Boothwyn Pharmacy and Precision Compounding."
    },
    {
      "id": "elevated",
      "name": "Elevated Health",
      "dossierUrl": "https://glp1dossier.com/is-elevated-legit",
      "providerUrl": "https://start.elevatedhealth.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Semaglutide ODT"
      ],
      "oralOffered": true,
      "priceFromUsd": 196,
      "promoPriceUsd": 96,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the $196 rate applies per kit of four injections on the 12-kit plan when paid in full upfront or through financing",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Elevate Your Wellness LLC dba Elevated alleging its compounded semaglutide and tirzepatide were misbranded because claims that they \"contain the same active ingredient as the branded medications\" implied equivalence to FDA-approved drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elevate-your-wellness-llc-dba-elevated-719811-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The main storefront named in the FDA letter blocks automated access, so prices were read from the company's own funnel site: $96 first treatment then $196 per kit, a kit being a set of four injections. Treatment plans are prepaid with nothing renewing automatically."
    },
    {
      "id": "embody",
      "name": "Embody",
      "dossierUrl": "https://glp1dossier.com/is-embody-legit",
      "providerUrl": "https://joinem.co/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 49,
      "promoPriceUsd": 49,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Precision Compounding Pharmacy",
        "HealthWarehouse",
        "Triad Rx"
      ],
      "membershipFee": "No separate membership fee; per Section XII of Embody’s Terms & Conditions and its Pre-Black Friday / Cyber Monday promotion (running 27 October through 1 December 2026), flat-dose compounded semaglutide is $49/mo on a 12-month bundle ($73/mo on 6-mo, $76/mo on 3-mo, or $79/mo month-to-month); flat-dose compounded tirzepatide is $99/mo on a 12-month bundle ($123/mo on 6-mo, $126/mo on 3-mo, or $129/mo month-to-month)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Embody (joinem.co; operated by Modern Metabolic Medicine, Inc. d/b/a Embody per Section XII of joinem.co/pages/terms-conditions) offers all-in flat-dose compounded semaglutide ($49/month on a 12-month bundle during its Pre-Black Friday / Cyber Monday sale running 27 October–1 December 2026, or $79/month month-to-month) and flat-dose compounded tirzepatide ($99/month on a 12-month bundle or $129/month month-to-month) with no separate membership fee. Cancellation requires at least 72 hours notice prior to the next billing date, and bundled commitments are non-refundable once prescribed except upon provider-initiated medical disqualification. Clinical consultations are provided through OpenLoop Health and fulfilled by four partner pharmacies named on joinem.co: Red Rock Compounding Pharmacy (St. George, UT), HealthWarehouse (Florence, KY), Precision Medicine / Precision Compounding Pharmacy (Bellmore, NY), and Triad Rx (Daphne, AL)."
    },
    {
      "id": "emerge",
      "name": "Emerge Weight Loss",
      "dossierUrl": "https://glp1dossier.com/is-emerge-legit",
      "providerUrl": "https://www.emergeweight.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 224,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded tirzepatide only, no semaglutide and no branded product. The $224 is per 4-week supply, i.e. 13 payments a year or about $243/month equivalent. Use emergeweight.com; emergeweightloss.com is a parked for-sale page. Markets its medication as 'enhanced with health-supporting peptides or vitamins', the additive-formulation framing Eli Lilly attacked in its 2025 suits against other compounders. BBB rating B, not accredited, 15 complaints; no FDA, FTC or AG action found."
    },
    {
      "id": "enhance-md",
      "name": "Enhance.MD",
      "dossierUrl": "https://glp1dossier.com/is-enhance-md-legit",
      "providerUrl": "https://enhance.md/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Semaglutide and tirzepatide combination",
        "Microdosed tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 212,
      "promoPriceUsd": 112,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Rite-Away Pharmacy",
        "Vios Compounding Pharmacy",
        "TruMedsRx"
      ],
      "membershipFee": "No membership fee on enhance.md (sibling brand EverPrime at joineverprime.com charges $99–$199/mo for member rates). Semaglutide is $212/mo ($112 first month), tirzepatide is $280/mo ($180 first month), semaglutide + tirzepatide combo is $322/mo ($222 first month), and microdosed tirzepatide is $169/mo.",
      "insurance": "cash",
      "intake": "labs",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Enhance.MD, LLC, with care delivered through Enhance Wellness PC, EnhanceMD CA PC and iThriveMD PC (Medical Director Dr. Erik Stark) and fulfillment through Rite-Away Pharmacy, Vios Compounding Pharmacy and TruMedsRx. In September 2026 Enhance.MD unified its Terms of Service with its sibling brand EverPrime (joineverprime.com). Onboarding requires a Quest Diagnostics blood panel and a live video consultation with a licensed provider before anything is prescribed, with metabolic lab testing every six months bundled into the subscription."
    },
    {
      "id": "everlywell",
      "name": "Everlywell (Weight Care+)",
      "dossierUrl": "https://glp1dossier.com/is-everlywell-legit",
      "providerUrl": "https://www.everlywell.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Zepbound",
        "other FDA-approved GLP-1s"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Weight Care+ membership with medication excluded; current price not published",
      "insurance": null,
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "unclear",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Everlywell, Inc. (everlywell.com). Its Weight Care+ telehealth membership historically listed $99–$139/month for 1:1 virtual visits and at-home lab testing with branded GLP-1 medication (such as Zepbound) paid separately at the pharmacy, though legacy Weight Care+ landing pages returned 404s during our October 2026 check."
    },
    {
      "id": "everprime",
      "name": "EverPrime",
      "dossierUrl": "https://glp1dossier.com/is-everprime-legit",
      "providerUrl": "https://joineverprime.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Semaglutide and tirzepatide combination",
        "Microdosed tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 214,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Rite-Away Pharmacy",
        "Vios Compounding Pharmacy",
        "TruMedsRx"
      ],
      "membershipFee": "Optional EverPrime Core ($99/mo) or Peak ($199/mo) membership reduces the displayed drug price by $99/mo, leaving the combined all-in cost identical to non-member pricing: semaglutide is $249/mo month-to-month or $214/mo on a 12-month plan ($115/mo drug + $99/mo Core membership); tirzepatide is $329/mo month-to-month or $280/mo on a 12-month plan; microdosed tirzepatide is $169–$189/mo.",
      "insurance": "cash",
      "intake": "labs",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Sibling brand of Enhance.MD, operated by the same legal entity (Enhance.MD, LLC) under unified Terms of Service effective 16 September 2026, with Dr. Erik Stark as Medical Director, clinical care through Enhance Wellness PC, EnhanceMD CA PC and iThriveMD PC, and 503A fulfillment through Rite-Away Pharmacy, Vios Compounding Pharmacy and TruMedsRx. The advertised '$115/mo' semaglutide and '$181/mo' tirzepatide member rates require an extra $99/mo Core or $199/mo Peak membership, bringing the true minimum outlay to $214/mo on a 12-month prepayment or $249/mo month-to-month. Includes Quest Diagnostics metabolic lab panels every six months and a 30-day Weight Loss Assurance refund window. Not available in AK, AR, HI, IN, LA, MA, MN, MS or SC. No FDA warning letter or regulatory action was found on record against Enhance.MD, LLC or EverPrime."
    },
    {
      "id": "ezra",
      "name": "Ezra",
      "dossierUrl": "https://glp1dossier.com/is-ezra-legit",
      "providerUrl": "https://joinezra.com",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Ezra Holdco LLC dba Ezra alleging its website labelling for compounded semaglutide and tirzepatide identified \"Ezra\" on the pictured label, suggesting Ezra was the compounder of those drugs when it was not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ezra-holdco-llc-dba-ezra-730995-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "single-source",
      "priceCheckedAt": "2026-11-16",
      "note": "The site is live and markets compounded semaglutide and tirzepatide, but publishes no prices or plan terms on public pages — pricing sits behind the intake flow."
    },
    {
      "id": "fancy-meds",
      "name": "Fancy Meds",
      "dossierUrl": "https://glp1dossier.com/is-fancy-meds-legit",
      "providerUrl": "https://fancymeds.com/us/products/glp-1-semaglutide",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "GLP-1 Semaglutide",
        "GLP-1/GIP Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": 149,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the alternative to $199 billed every four weeks is a $499 one-time payment covering a 12-week programme",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Fancy Meds, LLC alleging its compounded semaglutide and tirzepatide were misbranded because website claims that the products contained \"the same active ingredient as\" Ozempic, Wegovy, Mounjaro and Zepbound implied equivalence to FDA-approved drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancy-meds-llc-dba-fancy-meds-716487-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Semaglutide is listed at $199 per four weeks against a $249 compare-at price and tirzepatide at $299 against $399, with a promo code taking $50 off the first month. The site carries its own disclosure that compounded medications are not FDA-approved."
    },
    {
      "id": "fella-health",
      "name": "Fella Health",
      "dossierUrl": "https://glp1dossier.com/is-fella-health-legit",
      "providerUrl": "https://www.fellahealth.com/announcement",
      "supplies": "branded",
      "compoundingStatus": "ceased_compounding",
      "drugs": [
        "Wegovy",
        "Zepbound",
        "Ozempic",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "New GLP-1 program signups temporarily paused on fellahealth.com following resolution of Eli Lilly litigation; ceased advertising compounded GLP-1 medications",
      "insurance": "Transitioned to FDA-approved obesity medications following Eli Lilly settlement",
      "intake": "Online clinical evaluation through Fella Medical Group, P.C. / Fella Medical Group, P.A. (new signups temporarily paused)",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "Eli Lilly and Company filed a federal Lanham Act trademark infringement and false advertising lawsuit against Aios, Inc. d/b/a Fella Health and Delilah, Fella Medical Group P.A., and Fella Medical Group P.C. in the U.S. District Court for the Northern District of California (Case No. 4:25-cv-03535) over the marketing of compounded tirzepatide; Fella Health subsequently announced it resolved the legal dispute with Eli Lilly and immediately ceased advertising compounded GLP-1 offerings.",
          "source": "https://www.courtlistener.com/docket/69928868/eli-lilly-and-company-v-aios-inc/",
          "date": "2025-04",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Operated by Aios, Inc. d/b/a Fella Health and Delilah alongside Fella Medical Group, P.C. and Fella Medical Group, P.A. (fellahealth.com/membership-terms). Following an April 2025 federal lawsuit by Eli Lilly and Company (N.D. Cal. No. 4:25-cv-03535), Fella Health published an official settlement statement at fellahealth.com/announcement stating: 'Fella Health has resolved its legal dispute with Eli Lilly and Company. Starting immediately, we will no longer advertise compounded GLP-1 offerings, and we are excited to focus on our mission of helping solve obesity by offering patients access to FDA-approved medicines.' As of October 2026, fellahealth.com states new signups are temporarily paused while it updates its offers."
    },
    {
      "id": "fifty-410",
      "name": "Fifty 410",
      "dossierUrl": "https://glp1dossier.com/is-fifty-410-legit",
      "providerUrl": "https://www.fifty410.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide (503A pharmacy injection)",
        "Compounded Tirzepatide (503A pharmacy injection)"
      ],
      "oralOffered": false,
      "priceFromUsd": 149.5,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership or consultation fee ($0), and no credit card collected during online intake. Compounded tirzepatide and semaglutide programs start at $149.50/4 weeks ($299 total for an 8-week program shipped together), while single 4-week starter programs are $199 total (12-week bundles previously listed from $133/mo)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Aspen Aesthetics dba Fifty 410 alleging that the compounded semaglutide and tirzepatide products on its website identify \"Fifty 410\" on the pictured label, suggesting Fifty 410 is the compounder when it is not, and that its \"clinically proven ingredients\" claim implies the products were FDA-approved or evaluated for safety and effectiveness when they were not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Aspen Aesthetics, LLC, dba Fifty 410 Health (fifty410.com, frequently searched as Fifty 410 or 50410 weight loss; 1630 W Prosper Trail, Suite 620, Prosper, TX 75078). Prescriptions are fulfilled by independent state-licensed 503A compounding pharmacies (and formerly 503B outsourcing facilities prior to FDA shortage-list resolution) with free overnight/2-day refrigerated shipping included. No credit card is taken upfront during the async medical intake; payment is requested via secure link only after an independent licensed clinician approves a prescription. Per fifty410.com/refund-policy (effective September 8, 2026), a 100% refund is available after payment only if cancelled before the dispensing pharmacy begins compounding; once compounding starts or medication ships, no routine cancellation or refund is permitted."
    },
    {
      "id": "fitish",
      "name": "Fitish",
      "dossierUrl": "https://glp1dossier.com/is-fitish-legit",
      "providerUrl": "https://fitish.com/pages/weight-management-program",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide + B6",
        "Compounded Tirzepatide",
        "Oral Semaglutide Tablets",
        "Oral Tirzepatide Tablets",
        "GLP-1 Microdosing"
      ],
      "oralOffered": true,
      "priceFromUsd": 179,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership or consult fee; each price is a monthly supply including the provider consult, medication and shipping",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to FITISH alleging that \"FITISH\" appearing on compounded product labels suggested it was the manufacturer, and that statements such as \"Semaglutide is the active ingredient in ozempic\" and \"Tirzepatide is the active ingredient in Mounjaro and Zepbound\" misrepresented the compounded drugs as FDA-approved.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitish-728280-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Prices per monthly supply: GLP-1 microdosing $179, compounded semaglutide + B6 $219, microdose tirzepatide $269, compounded tirzepatide $339."
    },
    {
      "id": "fitrx",
      "name": "FitRx",
      "dossierUrl": "https://glp1dossier.com/is-fitrx-legit",
      "providerUrl": "https://fitrxapp.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Ozempic",
        "Wegovy",
        "Zepbound",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": 151,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee advertised; the $151/month semaglutide price requires buying quarterly, and 24/7 provider access is included",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to FitRX, LLC dba FitRx alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the FitRx name, representing it as the compounder when it was not, and because website claims such as \"semaglutide (active ingredient in Wegovy)\" implied the compounded products had been FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-fitrx-717987-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "FitRX, LLC is the legal entity behind several consumer brands including AM Rx and Zealthy; this record covers the FitRx brand only. It runs an insurance-coordination path advertising branded GLP-1s as low as $25/month with coverage, alongside a cash compounded path."
    },
    {
      "id": "form-health",
      "name": "Form Health",
      "dossierUrl": "https://glp1dossier.com/is-form-health-legit",
      "providerUrl": "https://www.formhealth.co/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Zepbound",
        "Wegovy",
        "Saxenda",
        "Contrave"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$299/month self-pay care program, or insurance copay/deductible; medication billed separately through insurance",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The most clinically intensive model in this set: monthly video visits with both a clinician and a registered dietitian, labs required, and an existing primary care physician relationship (visit within the past 12 months) is an eligibility gate. A named LillyDirect telehealth partner."
    },
    {
      "id": "found",
      "name": "Found",
      "dossierUrl": "https://glp1dossier.com/is-found-legit",
      "providerUrl": "https://www.joinfound.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "Wegovy",
        "Zepbound",
        "Ozempic",
        "Mounjaro",
        "Saxenda",
        "Victoza",
        "Foundayo",
        "metformin",
        "topiramate",
        "zonisamide",
        "Contrave"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": 79,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Bundled in the GLP-1 Program, billed per 28-day cycle. On 5 Nov 2026 joinfound.com/plans-and-pricing read “Cash plans from $149/mo, insurance plans from $79/mo”, with those figures based on 12-month plans paid up-front; monthly plans start at $199/mo with insurance (clinical visits billed to insurance and may require copays) and $269/mo cash-pay. Branded GLP-1 medication (Wegovy, Zepbound, Ozempic, Mounjaro) is billed separately; the page lists Wegovy and Zepbound from $650/mo and Ozempic at $1,100/mo. No plans available in California",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Found (joinfound.com; Found Health, Inc. per joinfound.com/terms/offer-terms-v3) charges a $199/month compounded GLP-1 program fee ($149 first month promo) or a coaching/Rx membership ($99–$129/month, or $49/month on 6-month commitment) when prescribing branded Wegovy, Zepbound, Ozempic, or Mounjaro (branded drug cost separate). Affiliated clinical care is delivered by Sequence Clinical PC / Found affiliated medical groups."
    },
    {
      "id": "fridays",
      "name": "Fridays",
      "dossierUrl": "https://glp1dossier.com/is-fridays-legit",
      "providerUrl": "https://joinfridays.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "Ozempic",
        "Zepbound",
        "Wegovy pill",
        "Wegovy pen"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "both",
      "intake": "labs",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "No separate membership, signup or lab fees; compounded plans include medication plus unlimited provider visits, coaching and dietitian support. Compounded semaglutide from $99/mo on the 12-month plan (code FOREVER12; $109, $129 and $149/mo on 6-, 3- and 1-month plans; list rate $279/mo). Compounded tirzepatide from $198/mo on the 12-month plan (code FOREVER500; $225, $232 and $259/mo on 6-, 3- and 1-month plans; list rate $389/mo). Fridays advertises these rates as price-locked; the lowest rates require committing to the longer plan. Branded Ozempic $1,498/mo and Zepbound $1,828/mo. Labs required via Quest and covered. Minimum BMI of 20 is well below the standard clinical threshold."
    },
    {
      "id": "fwd",
      "name": "FWD",
      "dossierUrl": "https://glp1dossier.com/is-fwd-legit",
      "providerUrl": "https://fwd.care/semaglutide",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide Injection",
        "Compounded Oral Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee, but $99/month for 0.25 mg semaglutide is the member rate; the same dose is shown at $199.99+ as a non-member",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to FWD Care, Inc. alleging claims such as \"Same active ingredient in Mounjaro and Zepbound\" for its compounded semaglutide and tirzepatide implied its products were the same as FDA-approved drugs, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fwd-care-inc-dba-fwd-716696-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only, and the site now states plainly that its compounded medication is not FDA-approved and is not the same as FDA-approved medications — a direct reversal of the comparative language the FDA cited. Oral semaglutide $149/mo, tirzepatide $199/mo."
    },
    {
      "id": "gala-health",
      "name": "Gala",
      "dossierUrl": "https://glp1dossier.com/is-gala-health-legit",
      "providerUrl": "https://galaglp1.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded GLP-1/GIP (tirzepatide-based)",
        "Microdosing GLP-1/GIP",
        "Compounded semaglutide",
        "Ozempic",
        "Wegovy pill"
      ],
      "oralOffered": true,
      "priceFromUsd": 129,
      "promoPriceUsd": 69,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee and the provider visit is included. On 5 Nov 2026 galaglp1.com/weight-loss showed a “From $69/mo, all doses included” banner alongside semaglutide from $129/mo and tirzepatide from $179/mo; the $69 rate is state-dependent and standard pricing still applies in some states. Earlier readings documented the $149/mo microdosing and $179/mo compounded rates on a yearly subscription and a 3-month plan at $199/mo",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Trades as Gala GLP-1 at galaglp1.com and also sells menopause and hormone therapy. Branded Ozempic is listed at $1,299/month; the Wegovy pill is shown as waitlist with no price. No FDA warning letter or other regulatory action was found on record against it."
    },
    {
      "id": "genesis",
      "name": "Genesis Health",
      "dossierUrl": "https://glp1dossier.com/is-genesis-legit",
      "providerUrl": "https://www.trygenesis.com/medications",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Ozempic",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 91.67,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Plans are billed in advance; the $91.67/month figure requires prepaying $1,100 annually for compounded semaglutide ($108.33/mo on 6 months, $116.67 on 3, $175 billed monthly); compounded tirzepatide is $125/mo on the annual plan ($1,500) and $225 billed monthly",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Genesis Health International Inc. alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the Genesis name, representing it as the manufacturer when it was not, and because website claims such as \"Contains the same active ingredient as Ozempic and Wegovy\" implied the compounded products had been FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genesis-health-international-inc-dba-genesis-721451-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Now carries branded Ozempic, Wegovy and Zepbound alongside its compounded products; branded Wegovy is advertised at $1,299 per month on the annual plan. The site states compounded medications are not FDA-approved."
    },
    {
      "id": "gobymeds",
      "name": "GobyMeds",
      "dossierUrl": "https://glp1dossier.com/is-gobymeds-legit",
      "providerUrl": "https://www.gobymeds.com/getting-started/pricing",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": 93,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate monthly membership fee ($50 clinical-review fee applies if a refund is requested after medical review begins); single-month compounded semaglutide is $169/month at any dose, while 3-month starter bundles are $299 total ($99/month equivalent, or $279 / $93/month Jumpstart promo) for semaglutide and $399 total ($133/month equivalent) for tirzepatide",
      "insurance": "Cash-pay for compounded medications (HSA/FSA accepted); branded Wegovy and Zepbound available separately",
      "intake": "Asynchronous medical intake reviewed by licensed clinicians (live consult where required by state law)",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Operated by Goby Health LLC (gobymeds.com/legal/terms-of-service). Publishes a full dose-by-dose price table at gobymeds.com/getting-started/pricing with flat single-month compounded semaglutide at $169/month across 0.25 mg to 2.5 mg tiers and multi-month starter bundles from $279–$299 for 3 months ($93–$99/month equivalent). Per Goby Health LLC's Terms of Service, orders cancelled after clinical review begins incur a $50 consultation deduction, and prescriptions cannot be refunded once transmitted to a partner 503A/503B compounding pharmacy. No FDA warning letter or federal enforcement action naming Goby Health LLC was found on record."
    },
    {
      "id": "goodgirlrx",
      "name": "GoodGirlRX",
      "dossierUrl": "https://glp1dossier.com/is-goodgirlrx-legit",
      "providerUrl": "https://goodgirlrx.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Tirzepatide",
        "Semaglutide ODT Pills",
        "Tirzepatide Pills",
        "Wegovy Pill",
        "Ozempic",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 134,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "The $134/mo rate requires the annual plan; quarterly is $144/mo and month-to-month $149/mo, with no cancellation fee",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Good Girl LLC dba GoodGirlRX alleging it misbranded compounded semaglutide and tirzepatide by displaying \"GoodGirlRX\" on the pictured labels, suggesting it was the compounder when it was not, and by website statements including \"FDA-approved meds\" and \"Clinically proven GLP-1 results\", which the agency said imply FDA approval the compounded products do not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/good-girl-llc-dba-goodgirlrx-721449-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Now sells branded drugs alongside its compounded line, and the site labels compounded products as not FDA-approved — a change from the \"FDA-approved meds\" claim cited in the February 2026 letter."
    },
    {
      "id": "goodlife-health",
      "name": "GoodLife Health",
      "dossierUrl": "https://glp1dossier.com/is-goodlife-health-legit",
      "providerUrl": "https://goodlifehealth.ai/membership",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy",
        "Zepbound",
        "Mounjaro",
        "Ozempic"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$299/month membership; $598 for the first two months is held at checkout and charged only once a clinician accepts you (then non-refundable), month to month from month 3 with cancellation any time by email or portal and no pro-rated refunds; includes one cardiometabolic lab panel every 90 days (4/year); brand-name GLP-1 medications are billed separately by the pharmacy, LillyDirect, NovoCare or insurance at their own price",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "GoodLife Health (goodlifehealth.ai) is a brand-name-only Direct Primary Care cardiometabolic membership run by two Arizona corporations at 1840 N Craycroft Rd, Tucson, AZ 85712: GoodLife Health Professional Corporation (clinical entity, owned by a nurse practitioner) and GoodLife Health Management Inc (technology, billing). Per its Corporate Structure page (August 2026) and Terms of Service (last updated October 2026), patients are treated by physicians of Beluga Health, P.A., an independent Florida professional association, in all 50 states. Membership is $299/month with a $598 two-month start, four Quest lab panels a year (Lipid panel, ApoB, Lipoprotein(a), hs-CRP, HbA1c, Fasting insulin, TSH with reflex to free T4, CMP, CBC with differential), and FDA-approved GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic) billed at pharmacy cost. Disputes go to AAA arbitration with a 30-day opt-out; Arizona law."
    },
    {
      "id": "goodrx",
      "name": "GoodRx for Weight Loss",
      "dossierUrl": "https://glp1dossier.com/is-goodrx-legit",
      "providerUrl": "https://www.goodrx.com/weight-loss",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Ozempic",
        "Wegovy",
        "Zepbound",
        "Foundayo"
      ],
      "oralOffered": false,
      "priceFromUsd": 119,
      "promoPriceUsd": 39,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$119/month telemedicine subscription from 1 February 2026 ($39/month introductory rate through January 2026); medication separate",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Launched 17 November 2025; explicitly avoids compounded alternatives. Ozempic and Wegovy pens are $199/month for the first two fills then $349/month. The coupon prices shown on goodrx.com drug pages are manufacturer savings-card prices for insured patients and are not cash prices. Pricing source is the company press release, so verify the live rate before publishing."
    },
    {
      "id": "harper-meds",
      "name": "Harper Meds",
      "dossierUrl": "https://glp1dossier.com/is-harper-meds-legit",
      "providerUrl": "https://www.harpermeds.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the site advertises one price covering consultation, prescription, four weeks of medication and shipping",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Nexus Health Solutions LLC dba Harper Meds alleging that \"Harper Meds\" on compounded product labels suggested it was the manufacturer, that the claim \"Same active ingredient as Ozempic & Wegovy\" implied FDA approval, and that describing its sources as \"FDA-licensed 503A Outsourcing Facilities\" was false because compounding facilities are not FDA-licensed.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Tirzepatide is advertised from $196/month, with the same price at every dose. The page does not disclose whether the $149 rate requires a multi-month prepayment."
    },
    {
      "id": "healthon",
      "name": "Healthon",
      "dossierUrl": "https://glp1dossier.com/is-healthon-legit",
      "providerUrl": "https://healthon.com/pages/weight-loss-program",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 183,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee disclosed; consultation and shipping are bundled into the subscription, with semaglutide from $189/mo or $549/quarter and tirzepatide from $295/mo",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Healthon Inc. alleging claims such as \"Same active ingredient as Wegovy and Ozempic\" and \"Clinically proven weight loss\" implied its compounded semaglutide and tirzepatide were the same as FDA-approved products, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthon-inc-dba-healthon-719809-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only, with prominent disclaimers that compounded GLP-1s are not FDA-approved replacing the equivalence claims the FDA cited. Its tirzepatide product page currently shows out of stock."
    },
    {
      "id": "healthrx",
      "name": "HealthRX",
      "dossierUrl": "https://glp1dossier.com/is-healthrx-legit",
      "providerUrl": "https://healthrx.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 105,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; on 14 Nov 2026 healthrx.com/products/semaglutide listed compounded semaglutide on “Commit & Save” plans at $105/month on the 12-month plan, $115/month on the 6-month plan and $125/month on the 3-month plan, each after a $39 first month, or $139/month month to month; healthrx.com/products/tirzepatide listed compounded tirzepatide at $159/month on the 12-month plan, $179/month on the 6-month plan and $199/month on the 3-month plan, each after a $39 first month, or $244/month month to month. Commit & Save plans include HealthRX’s membership (described as a $240/yr value) and its 10% member price; month-to-month carries no membership or member discount; an optional “Lifetime VIP” costs $149 once",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "States on its own site that compounded medications are not reviewed or approved by the FDA and are prepared by licensed compounding pharmacies under section 503A, and advertises LegitScript certification (cert. 50087439). No FDA warning letter or other regulatory action was found on record against it."
    },
    {
      "id": "healthy-male",
      "name": "Healthy Male",
      "dossierUrl": "https://glp1dossier.com/is-healthy-male-legit",
      "providerUrl": "https://healthymale.com/weight-loss/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "GLP SP",
        "GLP T",
        "Wegovy",
        "Zepbound",
        "Xenical",
        "Metformin HCL ER"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee, but Wegovy and Zepbound carry separately listed consultations at $79 each",
      "insurance": null,
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Healthy Male alleging its compounded tirzepatide was misbranded because claims including \"Clinically shown to support 15-22% average body weight reduction\" and \"Clinically proven to deliver sustainable results\" implied the compounded product was the same as an FDA-approved product.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-male-716506-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "single-source",
      "priceCheckedAt": "2026-11-16",
      "note": "A storefront-style site in Tempe, Arizona listing compounded GLP SP at $148.50 and GLP T at $268.50 alongside branded Wegovy and Zepbound at $1,599 each. The site does not state what supply duration each price covers, so the monthly basis is unconfirmed."
    },
    {
      "id": "henry-meds",
      "name": "Henry Meds",
      "dossierUrl": "https://glp1dossier.com/is-henry-meds-legit",
      "providerUrl": "https://henrymeds.com/treatments/weight-management/glp-1-weight-management/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "compounded liraglutide",
        "compounded oral semaglutide tablets & sublingual drops"
      ],
      "oralOffered": true,
      "priceFromUsd": 179,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "no",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Strive Pharmacy",
        "Empower Pharmacy",
        "Hallandale Pharmacy",
        "Tailor Made Compounding"
      ],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "Eli Lilly sued Adonis Health, Inc. d/b/a Henry Meds in the Northern District of California on 23 April 2025 (No. 4:25-cv-03536) over its marketing of compounded tirzepatide against Mounjaro and Zepbound. In September 2025 the court dismissed Lilly's safety and efficacy claims and allowed its personalisation claims to proceed.",
          "source": "https://www.govinfo.gov/content/pkg/USCOURTS-cand-4_25-cv-03536/pdf/USCOURTS-cand-4_25-cv-03536-0.pdf",
          "date": "2025-04",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating F, not accredited, with 232 complaints of which 26 unanswered; BBB states concerns primarily involve billing, cancellation and fulfillment issues.",
          "source": "https://www.bbb.org/us/ca/san-francisco/profile/health-and-wellness/henry-meds-1116-951367",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Henry Meds (henrymeds.com; HenrysMeds, operated by Adonis Health, Inc.) offers all-in month-to-month compounded semaglutide ($297/month ongoing after $179 first-month promo; higher dose tier +$100/month), oral semaglutide tablets/drops ($249/month), and compounded tirzepatide ($449/month), fulfilled via Hallandale Pharmacy, Empower Pharmacy, Tailor Made Compounding, and Strive Pharmacy."
    },
    {
      "id": "hers",
      "name": "Hers",
      "dossierUrl": "https://glp1dossier.com/is-hers-legit",
      "providerUrl": "https://www.forhers.com/weight-loss",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy Pill",
        "Wegovy Pen",
        "Zepbound Vial",
        "Zepbound KwikPen",
        "Ozempic",
        "Ozempic Pill",
        "Mounjaro",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": 149,
      "promoPriceUsd": 39,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$39 first month then $149/month; includes care team, nutrition guidance and smart scale; medication separate",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 3,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Hims & Hers Health, Inc. dba Hers (MARCS-CMS 716825) over compounded GLP-1 marketing.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "The FTC, the State of Utah and Los Angeles County sued Hims & Hers Health, Inc. in the Northern District of California under FTC Act section 5 and ROSCA, alleging the company disclosed customers' health information to advertising platforms including Meta and Snap, charged consumers before the promised provider consultation, and obstructed cancellation; allegations unproven. Hers is the same legal entity.",
          "source": "https://www.ftc.gov/news-events/news/press-releases/2026/07/ftc-states-act-against-hims-hers-deceptive-unlawful-privacy-practices",
          "date": "2026-07",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Novo Nordisk sued Hims & Hers for infringement of US Patent 8,129,343 in the District of Delaware on 9 February 2026 (No. 1:26-cv-00143) and voluntarily dismissed it without prejudice on 9 March 2026, expressly reserving the right to refile, under an agreement in which Hims & Hers stopped advertising compounded GLP-1s and began distributing Novo's FDA-approved semaglutide.",
          "source": "https://dockets.justia.com/docket/delaware/dedce/1:2026cv00143/91967",
          "date": "2026-03",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Same legal entity as Hims; FDA issued the two brands separate warning letters. Treat as one corporate risk profile with two consumer brands."
    },
    {
      "id": "hims",
      "name": "Hims",
      "dossierUrl": "https://glp1dossier.com/is-hims-legit",
      "providerUrl": "https://www.hims.com/weight-loss",
      "supplies": "branded",
      "compoundingStatus": "ceased_compounding",
      "drugs": [
        "Wegovy Pill",
        "Wegovy Pen",
        "Zepbound Vial",
        "Zepbound KwikPen",
        "Ozempic",
        "Ozempic Pill",
        "Mounjaro",
        "Foundayo (orforglipron)"
      ],
      "oralOffered": true,
      "priceFromUsd": 149,
      "promoPriceUsd": 39,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$39 first month then $149/month, auto-renewing; medication billed separately",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 4,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Novo Nordisk sued Hims & Hers for infringement of US Patent 8,129,343 in the District of Delaware on 9 February 2026 (No. 1:26-cv-00143) and voluntarily dismissed it without prejudice on 9 March 2026, expressly reserving the right to refile, under an agreement in which Hims & Hers stopped advertising compounded GLP-1s and began distributing Novo's FDA-approved semaglutide.",
          "source": "https://dockets.justia.com/docket/delaware/dedce/1:2026cv00143/91967",
          "date": "2026-03",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "The FTC, the State of Utah and Los Angeles County sued Hims & Hers Health, Inc. in the Northern District of California under FTC Act section 5 and ROSCA, alleging the company disclosed customers' health information to advertising platforms including Meta and Snap, charged consumers before the promised provider consultation, and obstructed cancellation; allegations unproven.",
          "source": "https://www.ftc.gov/news-events/news/press-releases/2026/07/ftc-states-act-against-hims-hers-deceptive-unlawful-privacy-practices",
          "date": "2026-07",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Consolidated securities class action, In re Hims & Hers Health, Inc. Securities Litigation, No. 25-cv-05315 (N.D. Cal.), first filed 25 June 2025, alleging misrepresentations about the company's business and its Novo Nordisk relationship; disclosed by the company in its Form 10-Q for the quarter ended 30 June 2026. Allegations unproven.",
          "source": "https://www.sec.gov/Archives/edgar/data/1773751/000177375126000163/R20.htm",
          "date": "2025-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "Novo Nordisk terminated its collaboration with Hims & Hers, alleging illegal sham compounding and Chinese-sourced unapproved API.",
          "source": "https://www.prnewswire.com/news-releases/novo-nordisk-terminates-collaboration-with-hims--hers-health-inc-due-to-concerns-about-their-illegal-mass-compounding-and-deceptive-marketing-302488189.html",
          "date": "2025-06",
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Hims was the flagship compounded-semaglutide seller but is branded-only as of the 9 March 2026 Novo Nordisk settlement; third-party content describing Hims as a compounder is out of date. Medication prices run $149/mo (Wegovy Pill) to $1,899/mo (Mounjaro, Zepbound) on top of the membership."
    },
    {
      "id": "hone-health",
      "name": "Hone Health",
      "dossierUrl": "https://glp1dossier.com/is-hone-health-legit",
      "providerUrl": "https://honehealth.com/mens/weight-loss/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Liraglutide"
      ],
      "oralOffered": true,
      "priceFromUsd": 160,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$160/month for compounded liraglutide medication (or $60–$65/month for oral generic weight-management medications) billed in addition to a mandatory Hone Health membership ($25/month Basic or $155/month Premium covering ongoing lab re-testing and physician consultations) and a mandatory $65 initial 50-biomarker lab panel",
      "insurance": "Cash-pay for membership and compounded medications (HSA/FSA eligible)",
      "intake": "Mandatory 50-biomarker blood panel ($65 via CLIA-certified Quest Diagnostics lab visit or at-home collection) followed by a synchronous live video consultation with a Hone-affiliated licensed physician; prescriptions are issued only upon a clinician’s determination of individual medical necessity",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-28",
      "note": "Hone Health (honehealth.com/mens/weight-loss/) is a physician-supervised longevity, hormone optimization (TRT/HRT), and metabolic telehealth platform for men and women rather than an asynchronous compounded-GLP-1 storefront. Enrolling requires completing a mandatory $65 50-biomarker diagnostic blood panel (conducted through CLIA-certified partner labs including Quest Diagnostics or via at-home collection) followed by a synchronous live video consultation with a Hone-affiliated licensed physician before any treatment plan is prescribed. Within its metabolic and weight-management program, Hone lists Compounded Liraglutide ($160/month) alongside peptide Sermorelin ($175/month) and FDA-approved generic oral weight-management medications (Naltrexone $60/mo, Bupropion $60/mo, Phentermine $65/mo, Topiramate $65/mo), billed in addition to a Hone membership ($25/month Basic or $155/month Premium covering biannual/quarterly lab testing and ongoing physician consultations). Compounded medications are not FDA-approved for safety, effectiveness, or quality, are dispensed strictly by state-licensed 503A compounding pharmacies pursuant to a patient-specific prescription when a physician determines an individual medical need, and are never guaranteed prior to clinical evaluation. No FDA warning letter or federal enforcement action naming Hone Health was found on record."
    },
    {
      "id": "humecare-plus",
      "name": "HumeCare+",
      "dossierUrl": "https://glp1dossier.com/is-humecare-plus-legit",
      "providerUrl": "https://humecare.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Physician-guided GLP-1 protocol (molecule not named in product copy)"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unspecified",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$199 a month, described on the site as a limited-time offer, with automatic refills and cancellation at any time. HSA and FSA accepted.",
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The site sells a GLP-1 protocol without naming the molecule anywhere in its product or pricing copy — semaglutide appears only in the reference citations at the foot of the homepage. Whether medication is included in the $199 is never stated, so it is recorded here as unknown rather than assumed. The footer cites UK regulators — the General Pharmaceutical Council, the Care Quality Commission and the MHRA — while the US address given is a registered-agent mail drop in Dover, Delaware."
    },
    {
      "id": "hydramed",
      "name": "HydraMed",
      "dossierUrl": "https://glp1dossier.com/is-hydramed-legit",
      "providerUrl": "https://hydramed.com/rx",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 399,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to HydraMed IV LLC dba HydraMed alleging that \"HydraMed\" on compounded semaglutide and tirzepatide labels suggested it was the manufacturer, and that its website claim that products came from an \"FDA-approved pharmacy\" was false because compounding pharmacies and outsourcing facilities are not FDA-approved or FDA-licensed.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydramed-iv-llc-dba-hydramed-728282-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "HydraMed's primary business is mobile IV therapy in Denver; GLP-1s sit inside its telehealth line at $399 per month with free shipping."
    },
    {
      "id": "ivim-health",
      "name": "Ivím Health",
      "dossierUrl": "https://glp1dossier.com/is-ivim-health-legit",
      "providerUrl": "https://ivimhealth.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "compounded liraglutide",
        "Wegovy pill",
        "Wegovy injectable",
        "Ozempic",
        "Mounjaro",
        "Zepbound",
        "Saxenda",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": 140,
      "promoPriceUsd": 65,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Mandatory $75/month Ivím membership (first month free on the current promo) charged on top of all medication plans. On 30 Oct 2026 ivimhealth.com listed compounded semaglutide at $65/month and compounded tirzepatide at $117/month on 12-month plans, so the lowest combined monthly floor is $140 ($65 + $75); earlier readings quoted tirzepatide from $133/month on a 6-month plan ($208 combined)",
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Ivim Services LLC dba Ivim (MARCS-CMS 721816), part of the February 2026 telehealth action over compounded GLP-1 marketing.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivim-services-llc-dba-ivim-721816-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Ivim Health (ivimhealth.com; Ivim Health, LLC per ivimhealth.com/membership-agreement/) requires a mandatory $74.99/month membership fee on top of all medication pricing. Compounded semaglutide starts at $133/month ($75/month on 12-month prepay), making the true all-in monthly floor $208/month ($150/month on 12-month prepay); compounded tirzepatide starts at $199/month plus the $74.99 membership ($274/month all-in)."
    },
    {
      "id": "ivy-rx",
      "name": "IVY RX",
      "dossierUrl": "https://glp1dossier.com/is-ivy-rx-legit",
      "providerUrl": "https://www.ivyrx.com/products/personalized-glp-1-injections",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide (injectable & sublingual)",
        "Compounded tirzepatide (injectable & sublingual)"
      ],
      "oralOffered": true,
      "priceFromUsd": 197,
      "promoPriceUsd": 77,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership or lab fee; month-to-month compounded semaglutide is $197/mo ($177 first-month promo; $157/mo or $117/mo promo on 3-mo plan; $137/mo or $97/mo promo on 6-mo plan; $97/mo or $77/mo promo on 12-mo prepaid plan); compounded tirzepatide is $297/mo ($277 first-month promo; $197/mo promo on 3-mo; $177/mo promo on 6-mo; $157/mo promo on 12-mo prepaid plan)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "IVY RX (ivyrx.com/products/personalized-glp-1-injections; Ivy Rx, PLLC) offers compounded semaglutide at $197/month month-to-month ($177 first-month promo; $77/month on 12-month prepay) and compounded tirzepatide at $297/month ($277 first-month promo; $157/month on 12-month prepay), plus sublingual oral drops and tablets. Prescriptions are non-refundable once sent to partner 503A compounding pharmacies."
    },
    {
      "id": "joi-and-blokes",
      "name": "Joi + Blokes",
      "dossierUrl": "https://glp1dossier.com/is-joi-and-blokes-legit",
      "providerUrl": "https://joiandblokes.com/glp-1/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded GLP-1",
        "Compounded GLP-1/GIP",
        "Liraglutide",
        "Zepbound",
        "Wegovy",
        "Ozempic",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Site states membership and consultation fees of $0; the $199/mo compounded rate is billed quarterly",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Joi and Blokes alleging it misbranded compounded semaglutide and tirzepatide by presenting them as equivalent to FDA-approved products such as Ozempic and Wegovy, and by displaying the Joi + Blokes name on labels of drugs it did not compound.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joi-and-blokes-dba-joi-blokes-728283-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded GLP-1/GIP is $299/mo with a $149 first month. The company does not bill insurance directly, but branded prescriptions can be routed to a local pharmacy where insurance may apply."
    },
    {
      "id": "join-josie",
      "name": "Join Josie",
      "dossierUrl": "https://glp1dossier.com/is-join-josie-legit",
      "providerUrl": "https://joinjosie.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide Injections",
        "Compounded Tirzepatide Injections",
        "Oral Semaglutide ODT Tablets",
        "Oral Tirzepatide ODT Tablets",
        "Ozempic",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 189,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; plans are billed upfront for 1, 3, 6 or 12 months and the advertised monthly price reflects the 12-month plan",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Join Josie alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the Join Josie name, representing it as the sole manufacturer when it was not, and because claims such as \"The same active ingredient found in the FDA-approved brand Wegovy\" implied the compounded products had been FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/join-josie-717986-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Now lists branded Ozempic, Wegovy and Zepbound alongside its compounded options. The $189 figure is the microdose maintenance plan; full-dose weight management is advertised from $194/mo."
    },
    {
      "id": "jrnys",
      "name": "JRNYS",
      "dossierUrl": "https://glp1dossier.com/is-jrnys-legit",
      "providerUrl": "https://jrnys.com/weight-loss/product/compounded-semaglutide-2",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Wegovy",
        "Ozempic",
        "Mounjaro",
        "Zepbound",
        "Saxenda"
      ],
      "oralOffered": false,
      "priceFromUsd": 89,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$89 to $169/month coaching and telehealth membership (billed monthly or quarterly); medication billed separately (compounded semaglutide starts at $199/month on top of membership, bringing the cash-pay floor to $288/month)",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "Better Business Bureau profile for JRNYS Wellness, Inc. (Austin, TX) records a C rating with 20 complaints closed over three years, centering on non-refundable membership charges where consumers expected medication to be included in the initial fee.",
          "source": "https://www.bbb.org/us/tx/austin/profile/health-and-wellness/jrnys-wellness-inc-0825-1000226658",
          "date": "2026-10",
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "JRNYS (jrnys.com/weight-loss/product/compounded-semaglutide-2) separates its required monthly coaching membership ($89/month on 12-month commitment or $169/month month-to-month, billed every 28 days) from medication cost. Compounded semaglutide starts at $199/month on top of membership ($288/month true all-in floor), and compounded tirzepatide is $275–$350/month on top ($364–$519/month all-in). Holds a C rating on the BBB profile with unresponded billing complaints."
    },
    {
      "id": "julymd",
      "name": "JulyMD",
      "dossierUrl": "https://glp1dossier.com/is-julymd-legit",
      "providerUrl": "https://julymd.com/collections/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Oral Semaglutide Drops",
        "Ozempic"
      ],
      "oralOffered": true,
      "priceFromUsd": 197,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to JulyMD alleging claims that its compounded semaglutide had \"the same active ingredient as Wegovy and Ozempic\" and offered \"the same effective ingredient but at a fraction of the price\" implied its product was the same as an FDA-approved drug, making it misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/julymd-716828-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Since the letter, JulyMD also lists branded Ozempic from $1,399/month alongside its compounded semaglutide programme at $197/mo, listed as 34% off $297/mo."
    },
    {
      "id": "k-health",
      "name": "K Health",
      "dossierUrl": "https://glp1dossier.com/is-k-health-legit",
      "providerUrl": "https://khealth.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy",
        "Saxenda"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "A membership fee exists but the amount is not disclosed; medication and lab tests are an additional cost",
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "unclear",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by K Health, Inc. (khealth.com). Historically offered primary-care and weight-management memberships prescribing branded Wegovy and Saxenda (with medication and labs billed separately), though standalone consumer weight-loss URLs returned 404s during our October 2026 audit as K Health shifted focus toward enterprise health-system partnerships."
    },
    {
      "id": "kin-meds",
      "name": "Kin Meds",
      "dossierUrl": "https://glp1dossier.com/is-kin-meds-legit",
      "providerUrl": "https://kinmeds.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Personalized GLP-1 (Semaglutide)",
        "Personalized GLP-1/GIP (Tirzepatide)",
        "Wegovy Injection",
        "Wegovy Pill",
        "Zepbound KwikPen",
        "Zepbound Vial",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": 149,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee advertised; the site states no hidden fees and offers a free consultation",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Kin Meds alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the Kin Meds name, representing it as the manufacturer when it was not, and because claims such as \"Same Active Ingredient as common brands\" implied the compounded products had been FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kin-meds-721450-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Now leads with branded options at $149/mo while still offering compounded semaglutide at $199 and tirzepatide at $249. The site notes that payment does not guarantee a prescription will be written."
    },
    {
      "id": "lemonaid",
      "name": "Lemonaid Health",
      "dossierUrl": "https://glp1dossier.com/is-lemonaid-legit",
      "providerUrl": "https://www.lemonaidhealth.com/services/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded tirzepatide",
        "compounded semaglutide",
        "compounded microdose tirzepatide",
        "compounded microdose semaglutide",
        "Wegovy",
        "Ozempic",
        "Zepbound",
        "metformin"
      ],
      "oralOffered": false,
      "priceFromUsd": 49,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$49/month weight-loss membership on top of medication cost",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Cannot accept insurance for any fee or medication. Publishes compounded and branded prices side by side: compounded tirzepatide $199-$299/mo, compounded semaglutide $249-$299/mo, branded Wegovy $1,599/mo, Ozempic $1,199/mo, Zepbound vials $299-$449/mo routed via LillyDirect. Carries the FDA-required disclosure that compounded medications are not FDA approved or verified."
    },
    {
      "id": "levity",
      "name": "Levity",
      "dossierUrl": "https://glp1dossier.com/is-levity-legit",
      "providerUrl": "https://www.joinlevity.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Mounjaro",
        "Wegovy",
        "Ozempic"
      ],
      "oralOffered": false,
      "priceFromUsd": 1199,
      "promoPriceUsd": 1149,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee — medication, prescription, consultation and shipping are all included in one monthly fee, billed roughly every four weeks",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Levity Inc. alleging it misbranded compounded semaglutide and liraglutide by displaying \"Levity\" on the pictured labels, suggesting Levity was the compounder when it was not, and by website claims such as \"The same ingredient as Ozempic + Wegovy\" and \"The power of Saxenda\" that the agency said imply FDA approval the compounded products do not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/levity-inc-dba-levity-717990-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Levity now lists only FDA-approved brand medication; no compounded semaglutide or liraglutide appears on its site, a change from the products described in the February 2026 letter. The high prices are brand cash-pay list prices bundled with the consultation."
    },
    {
      "id": "lifemd",
      "name": "LifeMD",
      "dossierUrl": "https://glp1dossier.com/is-lifemd-legit",
      "providerUrl": "https://www.lifemd.com/weight-management",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy pen",
        "Wegovy tablet",
        "Zepbound vial",
        "Zepbound KwikPen",
        "Ozempic",
        "Saxenda",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": 149,
      "promoPriceUsd": 39,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$39 first month then $149/month program membership; medication excluded",
      "insurance": "accepts",
      "intake": "labs",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating A but 827 complaints in the reporting period, with recurring themes of difficulty cancelling subscriptions and refund problems; BBB publishes only one in five complaints due to volume.",
          "source": "https://www.bbb.org/us/ny/new-york/profile/telemedicine/lifemd-inc-0121-183749",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "LifeMD (lifemd.com; Rx LifeMD, operated by LifeMD, Inc., NASDAQ: LFMD) charges a required Weight Management membership ($149/month month-to-month or $75–$99/month on 6-to-12-month commitment; medicationIncluded: false). Compounded semaglutide or tirzepatide ($150–$250/month) and branded Wegovy or Zepbound are billed separately on top of the membership fee."
    },
    {
      "id": "lillydirect",
      "name": "LillyDirect",
      "dossierUrl": "https://glp1dossier.com/is-lillydirect-legit",
      "providerUrl": "https://lillydirect.lilly.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Zepbound (tirzepatide)",
        "Foundayo (orforglipron)"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "no",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Truepill",
        "GiftHealth"
      ],
      "membershipFee": null,
      "insurance": "cash",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Eli Lilly and Company (MARCS-CMS 716485) finding that the company's participation in an ABC primetime special created a misleading impression regarding the safety of Zepbound and Mounjaro, and misbranded those drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Eli Lilly and Company’s official manufacturer direct-to-patient pharmacy channel (lillydirect.lilly.com; also searched as Lilly Direct Program), fulfilled by GiftHealth and Truepill. Supplies authentic FDA-approved Zepbound single-dose vials and pens starting at $299/month (2.5 mg starter dose) to $449/month (higher doses) on self-pay without insurance, with independent telehealth prescribers (such as Form Health, 9amHealth, Sesame and PlushCare) charging separate consultation fees."
    },
    {
      "id": "lumimeds",
      "name": "LumiMeds",
      "dossierUrl": "https://glp1dossier.com/is-lumimeds-legit",
      "providerUrl": "https://www.lumimeds.com/products",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 89,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership required, but the $89/mo semaglutide rate requires a 12-month plan paid $1,068 upfront; month-to-month is $189/mo, three months $133/mo and six months $115/mo",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Lumimeds alleging claims that its compounded products contained \"the same active ingredient as the brand name medications\" and that \"GLP-1 was FDA-approved in 2017\" implied its unapproved compounded drugs were the same as FDA-approved products, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lumimeds-716510-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only; the site now carries explicit disclaimers that compounded medications are not FDA-approved and that payment does not guarantee a prescription, a change from the language cited in the letter. Compounded tirzepatide starts at $125/mo."
    },
    {
      "id": "luvo-health",
      "name": "Luvo Health",
      "dossierUrl": "https://glp1dossier.com/is-luvo-health-legit",
      "providerUrl": "https://www.luvohealth.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide injection",
        "Semaglutide tablets",
        "Compounded tirzepatide injection",
        "Ozempic",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Not published. The site says pricing depends on the service and the recommended plan, and that the total cost is shown before checkout.",
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Listed by its affiliate network under peptides, but the company's own site runs a weight-loss programme naming semaglutide in injectable and tablet form, tirzepatide injection, Ozempic and Zepbound, which is why it belongs on this record. No price is published anywhere before checkout, so every figure here is left empty rather than estimated. No legal entity is named in the footer."
    },
    {
      "id": "maximus",
      "name": "Maximus",
      "dossierUrl": "https://glp1dossier.com/is-maximus-legit",
      "providerUrl": "https://www.maximustribe.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Tirzepatide",
        "Foundayo Tablets",
        "Wegovy Tablets",
        "Wegovy Pens",
        "Ozempic",
        "Zepbound",
        "Mounjaro"
      ],
      "oralOffered": true,
      "priceFromUsd": 99.99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; flat-dose base-form compounded tirzepatide is $99.99/mo on a 12-month plan ($119.99/mo on 6-mo, $149.99/mo on 4-mo, or $199.99/mo on 2-mo, billed upfront and shipped in 2-month batches), compounded semaglutide starts at $116 per 28-day supply, and FDA-approved branded options start at $199.99/mo (Foundayo tablets) to $1,249.99/mo (Mounjaro)",
      "insurance": "cash",
      "intake": "Asynchronous online medical evaluation reviewed by board-certified Maximus physicians (Weight Loss Protocol available nationwide except AL, MS, and LA)",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Maximus Health, Inc. dba Maximus alleging its website made false or misleading claims about compounded semaglutide and tirzepatide, including \"Proven to lose weight effectively\" and references to \"FDA approved pharmacies\" that represented the compounded products as FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-28",
      "note": "Maximus (maximustribe.com/weight-loss; operated by Maximus Health, Inc. d/b/a Maximus) is a men’s and women’s metabolic, hormone optimization (testosterone and enclomiphene protocols), hair loss (Warrior Hair Loss protocol), blood flow, and GLP-1 weight-loss telehealth platform serving over 50,000 clients. Its Weight Loss Protocol offers flat-dose base-form compounded tirzepatide ($99.99/month on a 12-month plan up to $199.99/month on a 2-month plan, shipped every 2 months with no membership fee) and compounded semaglutide ($116 per 28-day supply), alongside FDA-approved brand-name Foundayo tablets ($199.99/mo), Wegovy tablets ($249.99/mo), Wegovy pens ($349.99/mo), Ozempic ($349.99/mo), Zepbound ($449.99/mo), and Mounjaro ($1,249.99/mo), with HSA/FSA accepted and full refunds (less the doctor consultation fee) if not clinically approved. Following the June 2026 FDA warning letter (MARCS-CMS 730095) concerning website phrasing on compounded GLP-1 pages, Maximus updated maximustribe.com/weight-loss to prominently state in capital letters that compounded medications are not FDA-approved for safety, efficacy, or quality, explicitly specify the use of base-form tirzepatide rather than salt forms, and separate compounded pharmacy preparations from FDA-approved Novo Nordisk and Eli Lilly products in a side-by-side regulatory table."
    },
    {
      "id": "measured",
      "name": "Measured",
      "dossierUrl": "https://glp1dossier.com/is-measured-legit",
      "providerUrl": "https://trymeasured.com/medications",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Wegovy",
        "Ozempic",
        "Zepbound",
        "Mounjaro",
        "Wegovy Pill",
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "GLP-1 Microdose"
      ],
      "oralOffered": true,
      "priceFromUsd": 49,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Membership starts at $49/mo, cancel anytime; on branded medication the drug is billed separately at $149-$299/mo for the Wegovy Pill, $199-$349/mo for Wegovy and $299-$449/mo for Zepbound",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Better Health Labs, Inc. dba Measured alleging it misbranded compounded semaglutide and tirzepatide by displaying \"Measured\" on the pictured labels, suggesting Measured was the compounder when it was not, and by advertising products with \"the same active ingredients found in Wegovy, Ozempic, Zepbound, and Mounjaro\", which the agency said implies FDA approval the compounded products do not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/better-health-labs-inc-dba-measured-721454-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still sells both: compounded semaglutide from $119/mo and tirzepatide from $219/mo are medication-included cash-pay, while branded drugs are a $49/mo membership plus the drug, with insurance and prior authorisation handled. Ozempic and Mounjaro are marked insurance-required."
    },
    {
      "id": "medgm",
      "name": "MEDGm",
      "dossierUrl": "https://glp1dossier.com/is-medgm-legit",
      "providerUrl": "https://medgm.org/glp-1",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide injection",
        "Compounded tirzepatide injection",
        "Compounded semaglutide tablets",
        "Wegovy",
        "Zepbound",
        "Ozempic"
      ],
      "oralOffered": true,
      "priceFromUsd": 169,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Precision Compounding Pharmacy",
        "HealthWarehouse",
        "Triad Rx"
      ],
      "membershipFee": "Compounded plans bundle the provider consultation, lab work, side-effect medication and shipping at any dose. Read 11 Nov 2026 on MEDGm's product pages: semaglutide injections $169/mo on a 12-month supply ($2,028 billed at once), $189 on 6 months ($1,134), $199 on 3 ($597), $299 month to month ($179 first month); tirzepatide $269/$289/$299/$399 ($279 first month; $3,228 for 12 months); semaglutide tablets $239/$289/$319/$369. Brand-name Wegovy and Zepbound need a $99/mo membership ($171/mo for Ozempic) plus medication billed separately. Cancel at least 72 hours before the next billing date",
      "insurance": "cash",
      "intake": "labs",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by MEDGm, LLC, a Delaware LLC (medgm.org Terms of Use, last updated 9 August 2026), which describes itself as a technology and administrative platform; clinical care is given by providers of affiliated professional corporations that the terms do not name. The Terms of Use name four partner pharmacies with street addresses: RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Medicine (Bellmore, NY) and Triad Rx (Daphne, AL). Serves all 50 states and Washington, D.C. Its refund policy (medgm.org/refund) refunds months with no medication shipped on plans billed two or more months at a time, while the Terms of Use summary says bundles are not refundable on voluntary cancellation; disputes go to JAMS arbitration seated in Kent County, Delaware. No FDA warning letter or regulatory action was found on record against MEDGm, LLC."
    },
    {
      "id": "medica-weight-loss",
      "name": "Medica Weight Loss",
      "dossierUrl": "https://glp1dossier.com/is-medica-weight-loss-legit",
      "providerUrl": "https://medicaweightloss.com/semaglutide-weight-loss-injections/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Medica Weight Loss alleging it misbranded compounded semaglutide and tirzepatide by implying FDA approval, describing its compounding source as an \"FDA-approved pharmacy\", and putting its own branding on labels of drugs it did not compound.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medica-weight-loss-728284-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Semaglutide plans from $99/month on the 3-month program ($297 total, free shipping), per medicaweightloss.com (read 11 Nov 2026); a prescription is issued only after a provider consultation. The $197 first-month figure on earlier records no longer appears on the page."
    },
    {
      "id": "medvi",
      "name": "MEDVi",
      "dossierUrl": "https://glp1dossier.com/is-medvi-legit",
      "providerUrl": "https://medvi.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "single",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by MEDVi, LLC d/b/a MEDVi (medvi.com). Compounded semaglutide is $179 for the first month then $299/month for ongoing refills, and compounded tirzepatide is $299/month flat, with asynchronous consultation and shipping bundled. Received an FDA Warning Letter (MARCS-CMS 721455) on 20 February 2026 alleging its compounded semaglutide and tirzepatide pages carried MEDVi-branded vial labels that falsely implied MEDVi was the compounder and made unapproved equivalence claims to Wegovy and Ozempic."
    },
    {
      "id": "mint-med",
      "name": "Mint Med",
      "dossierUrl": "https://glp1dossier.com/is-mint-med-legit",
      "providerUrl": "https://mintmed.com",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 159,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Site states \"NO memberships\" — $159 per month covers the GLP-1 at all doses",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Glow Medispa, LLC dba Mint Med alleging its website labelling identified \"Mint Med\" on pictured compounded semaglutide and tirzepatide labels, suggesting Mint Med was the compounder of those drugs when it was not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-medispa-llc-dba-mint-med-730390-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Payment is collected upfront before clinical review. Care is asynchronous where state law allows, with a live visit scheduled in states that require one. HSA/FSA eligible; no insurance billing."
    },
    {
      "id": "mochi",
      "name": "Mochi Health",
      "dossierUrl": "https://glp1dossier.com/is-mochi-legit",
      "providerUrl": "https://joinmochi.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "Zepbound",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": 79,
      "promoPriceUsd": 49,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Aequita Pharmacy"
      ],
      "membershipFee": "Health membership without qualifying insurance: $79/month, or $49/month for as long as you stay on a 12-month plan; on 30 Oct 2026 new subscribers on the 1-month plan were offered a $0 first month (then $79/month). Insurance plan membership from $17/month. Medication is self-pay and billed separately (branded Zepbound from $299, Wegovy from $199, Foundayo from $149 as listed); lab panels from $26",
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 3,
      "regulatoryActions": [
        {
          "what": "Eli Lilly sued Mochi Health Corp. in the Northern District of California on 23 April 2025 (No. 3:25-cv-03534) over compounded tirzepatide combined with additives including niacinamide, pyridoxine and glycine. In October 2025 the court granted Mochi's motion to dismiss with leave to amend, holding Lilly had not established standing on reputational harm alone.",
          "source": "https://www.govinfo.gov/content/pkg/USCOURTS-cand-3_25-cv-03534/pdf/USCOURTS-cand-3_25-cv-03534-0.pdf",
          "date": "2025-04",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Novo Nordisk sued Mochi Health Corp. and its affiliated medical practices in the Northern District of California on 4 August 2025 (No. 5:25-cv-06563), alleging false advertising and unlawful mass compounding of semaglutide, including converting standard doses to non-standard ones and adding vitamin B12; allegations unproven.",
          "source": "https://storage.courtlistener.com/recap/gov.uscourts.cand.453985/gov.uscourts.cand.453985.1.0.pdf",
          "date": "2025-08",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "The Washington State Pharmacy Quality Assurance Commission issued a Limited Stop Service order on 13 March 2025 against Aequita Pharmacy LLC of Kirkland, Washington — reported to compound for Mochi Health — barring it from compounding or dispensing compounded products in the state, citing untrained and unqualified staff performing sterile compounding, inadequate supervision, and failure to follow sterile compounding procedures.",
          "source": "https://doh.wa.gov/newsroom/pharmacy-quality-assurance-commission-issues-limited-stop-service-license-pharmacy",
          "date": "2025-03",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating A but not accredited, with 1,378 complaints; themes include membership and medication subscriptions having to be cancelled separately, charges continuing after cancellation, and medication arriving heat-damaged.",
          "source": "https://www.bbb.org/us/ca/san-francisco/profile/health-care/mochi-health-1116-955238",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Mochi Health Corp. (joinmochi.com). Compounded semaglutide is $99/month ($60/month on select multi-month promos) and compounded tirzepatide is $199/month ($90/month on select promos) billed on top of the mandatory $79/month membership ($139–$178/month combined floor). Mochi faces a December 2024 Eli Lilly federal lawsuit (3:24-cv-09313) alleging it routed prescriptions through tiny-volume compounder Aequita Pharmacy and added unstudied vitamins to claim personalized dosing, and Washington State DOH restricted Aequita Pharmacy’s license in March 2025 over sterile compounding violations. No FDA warning letter directly naming Mochi Health Corp. was found."
    },
    {
      "id": "momentum-health",
      "name": "Momentum Health",
      "dossierUrl": "https://glp1dossier.com/is-momentum-health-legit",
      "providerUrl": "https://www.momentumhealth360.com/collections/weightloss/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Compounded Liraglutide"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Site states \"No hidden membership fees\"; billing is month-to-month with no lock-in",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Momentum Health 360 dba Momentum Health alleging its website labelling identified \"Momentum Health\" on pictured compounded semaglutide, tirzepatide and liraglutide labels, suggesting it was the compounder when it was not, and that claims including \"Same active ingredient in Mounjaro and Zepbound\" and describing compounding facilities as \"FDA-licensed\" were false or misleading.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/momentum-health-360-dba-momentum-health-728286-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded liraglutide starts at $299, semaglutide at $325 and tirzepatide at $499, shipping included, HSA/FSA eligible."
    },
    {
      "id": "mydrhank",
      "name": "MyDrHank",
      "dossierUrl": "https://glp1dossier.com/is-mydrhank-legit",
      "providerUrl": "https://mydrhank.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Oral semaglutide",
        "Oral semaglutide + ondansetron",
        "Compounded semaglutide injection (with B12 or glycine)",
        "Compounded tirzepatide injection (with B12 or glycine)"
      ],
      "oralOffered": true,
      "priceFromUsd": 171,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Midtown Express Pharmacy"
      ],
      "membershipFee": "No separate membership fee; the $171/mo oral semaglutide, $178/mo injectable semaglutide and $240/mo injectable tirzepatide headline rates require a 12-month plan ($2,057–$2,883 total), whereas single-month plans are $249/mo, $259/mo and $349/mo respectively. Promotional landing pages offer a $99 first month on 3-month or longer commitments.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "Novo Nordisk Inc. sued Dr. Hank, LLC (then doing business as 247 Health alongside Dunklau Pharmacy Holdings, LLC d/b/a Midtown Express Pharmacy) in the Middle District of Tennessee on 30 May 2024 (No. 3:24-cv-00667) for Lanham Act false advertising and unfair competition over unapproved compounded semaglutide. On 13 August 2024 the court entered a Final Judgment and Permanent Injunction on Consent permanently enjoining Dr. Hank, LLC from marketing or selling unapproved compounded semaglutide drugs unless it notifies Novo Nordisk and engages in good-faith discussions regarding legal compliance.",
          "source": "https://law.justia.com/cases/federal/district-courts/tennessee/tnmdce/3:2024cv00667/99691/29/",
          "date": "2024-08",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Dr. Hank, LLC in Nashville, Tennessee (300 20th Ave N #105, Nashville, TN 37203; MYDRHANK trademark registered to Dr. Hank, LLC with consent of Henry J. Dunklau IV). Despite consenting in August 2024 to a federal permanent injunction in the Middle District of Tennessee barring it from marketing or selling unapproved compounded semaglutide without first notifying Novo Nordisk, Dr. Hank, LLC currently markets oral semaglutide (plain or with ondansetron) and injectable compounded semaglutide and tirzepatide (formulated with vitamin B12 or glycine) across all dose tiers at mydrhank.com. Partner pharmacies are not named on the site ('available upon request'), and its Terms of Use note that dispensed medications are not shipped in child-resistant packaging."
    },
    {
      "id": "nativemed",
      "name": "NativeMed",
      "dossierUrl": "https://glp1dossier.com/is-nativemed-legit",
      "providerUrl": "https://www.nativemed.net/products/semaglutide",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Site states no membership fees; the $149/mo semaglutide rate is tied to a 3-month starter subscription rather than a single month",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to NativeMed LLC alleging it misbranded compounded tirzepatide by displaying its own logo on labels of drugs it did not compound, and marketed compounded semaglutide as containing \"The same active ingredient in Ozempic and Wegovy\", implying FDA approval it does not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nativemed-llc-dba-nativemed-728287-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Semaglutide is listed at $149 against a $299 compare-at price and tirzepatide at $183 against $399. Compounded medication is not covered by insurance."
    },
    {
      "id": "newself",
      "name": "NewSelf",
      "dossierUrl": "https://glp1dossier.com/is-newself-legit",
      "providerUrl": "https://www.newself.com",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide+",
        "Tirzepatide+"
      ],
      "oralOffered": false,
      "priceFromUsd": 99.97,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "The site states there are no membership fees and no surprise charges, and advertises a free visit; per its homepage (read 11 Nov 2026) Semaglutide+ is “as low as” $99.97/mo ($134.99 month to month) and Tirzepatide+ “as low as” $144.49/mo ($224.99 month to month)",
      "insurance": "cash",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to NewSelf Limited alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the NewSelf name, representing it as the manufacturer when it was not, and because website claims such as \"Same active ingredient as Ozempic & Wegovy\" and references to \"FDA-approved use\" implied the compounded products had been FDA-approved.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/newself-limited-dba-newself-721472-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only, with the disclosure that compounded drugs are not FDA-approved. Products are sold as Semaglutide+ and Tirzepatide+ with added vitamins; B12 and ondansetron are sold separately from $74/month."
    },
    {
      "id": "nexlife",
      "name": "Nexlife",
      "dossierUrl": "https://glp1dossier.com/is-nexlife-legit",
      "providerUrl": "https://nexlife.us/products/buy-semaglutide-online",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 95,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; compounded semaglutide is $109/mo month to month, $105/mo on a 3-month plan, $99/mo on 6 months or $95/mo on 12 months, same price at every dose (read 11 Nov 2026)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Nexlife Inc. dba Nexlife alleging its website labelling identified \"Nexlife\" on pictured compounded semaglutide and tirzepatide labels, suggesting Nexlife was the compounder of those drugs when it was not, and that its representations about the products were false or misleading.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexlife-inc-dba-nexlife-730096-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded tirzepatide is $129/mo at every dose; multi-month tirzepatide prices are not shown on the homepage (read 11 Nov 2026). The site itself states compounded medications are not FDA-approved."
    },
    {
      "id": "noom",
      "name": "Noom (Noom Med)",
      "dossierUrl": "https://glp1dossier.com/is-noom-legit",
      "providerUrl": "https://www.noom.com/med/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "Wegovy",
        "Ozempic",
        "Zepbound",
        "Mounjaro",
        "Foundayo",
        "liraglutide",
        "metformin"
      ],
      "oralOffered": false,
      "priceFromUsd": 179,
      "promoPriceUsd": 49,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership on the compounded tiers (all-inclusive); the branded telehealth tier is $39 first month then $99/month care fee with medication billed separately",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 2,
      "regulatoryActions": [
        {
          "what": "NAD (BBB National Programs) decision, challenged by Eli Lilly, recommended Noom discontinue or modify its 'Microdose GLP-1Rx' claims for lack of support that the lower dose delivers a measurable health benefit; Noom disagreed but agreed to comply.",
          "source": "https://bbbprograms.org/media/newsroom/decisions/noom",
          "date": "2026-05",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Nichols et al. v. Noom Inc., No. 1:20-cv-03677 (S.D.N.Y.) — a consolidated class action over auto-enrolment and auto-renewal practices, in which Geraldine Mahood was a named plaintiff — received final approval on 12 July 2022 of a settlement establishing a $56 million gross settlement fund plus reforms to Noom's enrolment and cancellation practices.",
          "source": "https://law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2020cv03677/536999/518/",
          "date": "2022-07",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Noom, Inc. (noom.com; also searched as Noom Med, Noom Rx and Saxenda Care Noom). Compounded semaglutide starts at $149 for the first month then $199/month billed in 3-month cycles ($597 every 12 weeks), with clinical visits, medication and behavioural app coaching bundled. Branded Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda prescriptions are also supported with medication paid separately at the pharmacy."
    },
    {
      "id": "novarx",
      "name": "NOVARX",
      "dossierUrl": "https://glp1dossier.com/is-novarx-legit",
      "providerUrl": "https://novarx.co",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Nova Vascular LLC dba NOVARX alleging it misbranded compounded semaglutide and tirzepatide by advertising \"access to the same active ingredient found in Ozempic\", claiming products came from \"FDA Approved Pharmacies\", and displaying \"NOVA RX\" on labels of drugs it did not compound.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nova-vascular-llc-dba-novarx-728290-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "single-source",
      "priceCheckedAt": "2026-11-16",
      "note": "The site is live but blocks automated retrieval, so no pricing or plan details could be read from its own pages. The drug names and marketing claims recorded here come from the FDA letter's quotations of the site."
    },
    {
      "id": "novocare",
      "name": "NovoCare Pharmacy",
      "dossierUrl": "https://glp1dossier.com/is-novocare-legit",
      "providerUrl": "https://www.novocare.com/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy pill",
        "Wegovy pen",
        "Wegovy HD"
      ],
      "oralOffered": true,
      "priceFromUsd": 149,
      "promoPriceUsd": 199,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Novo Nordisk, Inc. (MARCS-CMS 716495) finding that the same ABC primetime special minimised and omitted risk information, creating a misleading impression regarding the safety of Wegovy, Ozempic and Victoza.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Manufacturer-direct self-pay channel, not a telehealth provider. Time-sensitive pricing: Wegovy pill is $149/month for 1.5mg and 4mg, rising to $199/month for 2.4mg from 1 September 2026; the pen is $199/month for new patients at 0.25-0.5mg for two months through 31 December 2026, then $349/month, and $399 for Wegovy HD 7.2mg. Several telehealth entries simply resell these rates, so their prices move in lockstep."
    },
    {
      "id": "oak-weight-loss",
      "name": "Oak",
      "dossierUrl": "https://glp1dossier.com/is-oak-weight-loss-legit",
      "providerUrl": "https://www.oaklovesyou.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Tirzepatide",
        "Semaglutide"
      ],
      "oralOffered": false,
      "priceFromUsd": 109,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "None — the site states no hidden membership fees, no surprise charges, and free shipping",
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Trades as Oak / Oak Longevity. On 7 Nov 2026 the homepage (oaklovesyou.com) advertised “Prescription weight loss from $109/mo” and “GLP-1 Treatments for weight loss from $109/mo” (previously recorded $190 on the weight-loss page and $119 as a catalogue-wide homepage floor). The dedicated /weight-loss page did not print a dollar figure in the HTML fetched that day. No video call is required and approval can be same-day. No FDA warning letter or other regulatory action was found on record against it."
    },
    {
      "id": "orderlymeds",
      "name": "OrderlyMeds",
      "dossierUrl": "https://glp1dossier.com/is-orderlymeds-legit",
      "providerUrl": "https://orderlymeds.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": 74,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to OrderlyMeds LLC dba OrderlyMeds (MARCS-CMS 728291), part of the June 2026 round over compounded GLP-1 marketing.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded semaglutide $74 first month then $149/month; compounded tirzepatide $149 then $299/month; branded Wegovy $1,839/month and Zepbound $1,498/month. Starter pricing applies only to patients beginning at the lowest dose with full upfront payment. A video consultation is required only where the patient's state mandates it."
    },
    {
      "id": "pallas-health",
      "name": "Pallas Health",
      "dossierUrl": "https://glp1dossier.com/is-pallas-health-legit",
      "providerUrl": "https://www.pallashealth.co/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Wegovy",
        "Ozempic",
        "Zepbound",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": 139,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "One price with provider care included and no separate membership fee; compounded semaglutide is $139 for the first month, then $199 every 4 weeks, or $139/mo average on the annual plan; compounded tirzepatide is $179 for the first month, then $299 every 4 weeks, or $239/mo average on the annual plan (read 11 Nov 2026)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Explicitly cash-pay only and not billed to insurance, though FSA/HSA is eligible. Also runs an NAD+ programme and sermorelin. No FDA warning letter or other regulatory action was found on record against it."
    },
    {
      "id": "peaks",
      "name": "Peaks",
      "dossierUrl": "https://glp1dossier.com/is-peaks-legit",
      "providerUrl": "https://peakscurative.com/weight-loss-solutions/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "GLP-1 Monthly Weight Loss Program",
        "GIP and GLP-1 Monthly Weight Loss Program",
        "GLP-1 Dissolvable Melts",
        "GLP-1 Oral Solution"
      ],
      "oralOffered": true,
      "priceFromUsd": 190,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; the consultation is included and every-four-weeks subscription pricing is discounted against one-time purchase",
      "insurance": "cash",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Peaks Curative, LLC alleging it misbranded compounded semaglutide by displaying \"Peak Now\" on the pictured label, suggesting it was the compounder when it was not, and by website statements including \"This FDA-approved treatment promotes safe, effective weight loss\" and \"Clinically proven to aid in significant weight loss\", which the agency said imply FDA approval the compounded products do not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peaks-curative-llc-dba-peaks-721817-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Peaks sells only compounded formulations, marketed generically as GLP-1 and GIP/GLP-1 programmes plus melts and an oral solution, with no branded medication listed. The GIP and GLP-1 programme runs $269.99-$399.99 depending on dose and billing."
    },
    {
      "id": "peter-md",
      "name": "PeterMD",
      "dossierUrl": "https://glp1dossier.com/is-peter-md-legit",
      "providerUrl": "https://getpetermd.com/glp1-b12/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": 105,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate monthly membership fee; $149/month starter rate requires upfront payment of $447 for an estimated 10–12 week supply (or $315 for a 90-day supply / $105/month equivalent); returning users pay $139/month billed at $834 for 6 months",
      "insurance": "Cash-pay only; no insurance required",
      "intake": "Online medical intake and telehealth clinician review (not available in AL, ID, AK, or HI)",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "PeterMD (getpetermd.com/glp1-b12/) markets compounded Semaglutide + Vitamin B12 and Tirzepatide + Vitamin B12 injections shipped directly from US compounding pharmacies. New patients can purchase a 90-day semaglutide starter supply for $315 ($105/month equivalent) or a 10–12 week starter supply at $149/month ($447 upfront), while compounded tirzepatide starter supplies begin at $315; ongoing refills for returning patients are billed upfront on 6-month cycles ($834 total for semaglutide). Service is excluded in Alabama, Idaho, Alaska, and Hawaii. No FDA warning letter or federal enforcement action naming PeterMD was found on record."
    },
    {
      "id": "pharmazee",
      "name": "PharmaZee",
      "dossierUrl": "https://glp1dossier.com/is-pharmazee-legit",
      "providerUrl": "https://www.pharmazee.co/product/glp-1-medications/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compound Semaglutide",
        "Compound Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to PharmaZee alleging its website's compounded semaglutide and tirzepatide labels displayed the PharmaZee name, suggesting PharmaZee is the compounder when it is not, and that claims such as \"clinically proven medications\" and \"Same active ingredient as Ozempic and Wegovy\" imply the products were FDA-approved or evaluated for safety and effectiveness when they were not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmazee-721473-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Flat monthly pricing at the same rate for every dose: semaglutide from $99/month and tirzepatide from $149/month, with consultation, medication and shipping included. No insurance policy is stated anywhere on the site."
    },
    {
      "id": "plexusdx",
      "name": "PlexusDx",
      "dossierUrl": "https://glp1dossier.com/is-plexusdx-legit",
      "providerUrl": "https://plexusdx.com/pages/weight-management-protocols",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide (injectable)",
        "Compounded semaglutide (oral dissolving tablet)",
        "Compounded tirzepatide (injectable)",
        "Compounded tirzepatide (oral tablet)",
        "Microdose GLP-1 (oral or injectable)"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; full-dose compounded semaglutide (injection or oral tablet) is $149/mo month-to-month, $129/mo on 3-month prepay ($387), $109/mo on 6-month prepay ($654) or $99/mo on 12-month prepay ($1,188); compounded tirzepatide (injection or oral) is $189/mo month-to-month down to $129/mo on 12-month prepay ($1,548); Microdose GLP-1 is $99/mo month-to-month or $69/mo on 12-month prepay ($828)",
      "insurance": "cash",
      "intake": "both",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "PlexusDx (plexusdx.com/pages/weight-management-protocols; operated by PlexusDx, Inc., LegitScript certified per its site) combines optional pharmacogenomic testing with flat-price compounded GLP-1 protocols, injection or tablet at the same price (read 11 Nov 2026): semaglutide $149/mo month to month, $129 on 3 months ($387), $109 on 6 ($654), $99 on 12 ($1,188 up front); tirzepatide $189/$169/$149/$129 ($1,548 for 12 months); Microdose GLP-1 $99/$89/$79/$69. Optional anti-nausea medication $45 every 3 months; optional genetic test $99 after the first month. PlexusDx says it is not a medical practice, pharmacy or the merchant of record for prescription medication: an independent clinician network on a state-licensed telehealth platform prescribes, a licensed 503A pharmacy compounds, and the practice-management platform bills; none of these is named on the pages read on 11 Nov 2026. Cards are charged only once a prescription is sent to the pharmacy; plans renew automatically at the same length until future renewals are cancelled."
    },
    {
      "id": "plushcare",
      "name": "PlushCare",
      "dossierUrl": "https://glp1dossier.com/is-plushcare-legit",
      "providerUrl": "https://plushcare.com/weight-loss/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Zepbound",
        "Wegovy",
        "Saxenda",
        "Mounjaro",
        "Ozempic",
        "Victoza"
      ],
      "oralOffered": false,
      "priceFromUsd": 19.99,
      "promoPriceUsd": 0,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$19.99/month membership with the first month free, plus a $129 initial visit without insurance (or a copay with insurance); medication excluded",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Owned by Accolade. The low membership excludes almost everything: the real cost is the visit fee plus full medication price, stated on the page as usually about $1,000 per month without coverage. Video visit and labs are both required. Promo is a free first month, not a discounted rate."
    },
    {
      "id": "premium-health",
      "name": "Premium Health",
      "dossierUrl": "https://glp1dossier.com/is-premium-health-legit",
      "providerUrl": "https://premiumhealth.us/weight-loss/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 275,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "no",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Month-to-month membership including the medication; higher doses add $100/month for semaglutide and $150/month for tirzepatide, and 30 days' notice is required to cancel",
      "insurance": "cash",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Premium Health Management Inc. alleging its website's compounded semaglutide and tirzepatide labelling identified Premium Health as the compounder when it is not, and that website claims referencing Ozempic, Wegovy and Mounjaro and describing the products as \"generic compounded medication\" imply FDA approval or evaluation that has not occurred.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/premium-health-management-inc-dba-premium-health-721474-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded semaglutide at $275/month and tirzepatide at $445/month, billed as an all-inclusive membership. Intake requires a two-way audiovisual telehealth visit."
    },
    {
      "id": "push-health",
      "name": "Push Health",
      "dossierUrl": "https://glp1dossier.com/is-push-health-legit",
      "providerUrl": "https://www.pushhealth.com/services/weight-loss",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Ozempic",
        "Mounjaro",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "A prescription-writing service, not a supplier: it sends prescriptions to a pharmacy or manufacturer program of the patient's choice, with no subscription and no compounding exposure. The quoted 'approximately $149-$449/month' is the LillyDirect/NovoCare self-pay range, not a Push Health price. Eligibility generally BMI 30+, or 27+ with a weight-related condition; cannot prescribe controlled weight-loss drugs such as phentermine or Qsymia."
    },
    {
      "id": "ready-med",
      "name": "Ready Med",
      "dossierUrl": "https://glp1dossier.com/is-ready-med-legit",
      "providerUrl": "https://readymednow.com/semaglutide/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide",
        "Oral Semaglutide Tablets & Drops",
        "Liraglutide"
      ],
      "oralOffered": true,
      "priceFromUsd": 199,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Prices include medication and provider visits; higher semaglutide doses up to 2mg/week add $100/month. Month-to-month with no minimum term",
      "insurance": "cash",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Ready Med alleging it misbranded compounded semaglutide and tirzepatide by marketing them as \"The same active ingredient in Mounjaro and Zepbound\" and \"The same active ingredient in Ozempic and Rybelsus\", claiming they came from an \"FDA licensed compounding facility\", and displaying \"Ready Med\" on labels of drugs it did not compound.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ready-med-730317-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Semaglutide is $99 the first month then $199; tirzepatide is $449 per month and compounded liraglutide starts at $297. Cash-pay only, with a stated 30-day refund guarantee."
    },
    {
      "id": "refills-health",
      "name": "Refills",
      "dossierUrl": "https://glp1dossier.com/is-refills-health-legit",
      "providerUrl": "https://www.refills.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Personalized GLP-1",
        "Personalized GIP + GLP-1",
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership, app or cancellation fees; month-to-month with no contract",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Refills Health, LLC alleging its website's compounded semaglutide labelling displayed the Refills Health name, suggesting it is the compounder when it is not, and that claims including \"clinically proven\" and \"the same active ingredient found in certain FDA approved treatments\" imply the products were FDA-approved or evaluated for safety and effectiveness when they were not.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/refills-health-llc-dba-refills-health-721475-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Semaglutide as low as $99/month and tirzepatide as low as $159/month, same price at every dose. Product pages carry a 40% off badge with no pre-sale price published, so it is unclear whether $99 is the discounted or the list figure. Refills states it is a technology platform, not a medical services provider."
    },
    {
      "id": "remedy-meds",
      "name": "Remedy Meds",
      "dossierUrl": "https://glp1dossier.com/is-remedy-meds-legit",
      "providerUrl": "https://remedymeds.com/medication/comp-sema-inj",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "GLP-1 Microdose Plan",
        "Ozempic",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 299,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; one price month-to-month with a price-lock guarantee and no multi-month prepay",
      "insurance": "cash",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Remedy Meds alleging website claims such as \"Semaglutide (Compounded) Same active ingredient as Ozempic and Wegovy\" and \"Tirzepatide (Compounded) Same active ingredient as Mounjaro and Zepbound\" implied its compounded products were the same as FDA-approved drugs, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Since the letter, Remedy Meds also routes patients to branded Ozempic and Zepbound at retail pricing alongside its compounded plans. Compounded semaglutide is $179 the first month then $299; tirzepatide is $279 then $399. Unlimited clinician video calls included."
    },
    {
      "id": "ro",
      "name": "Ro (Ro Body)",
      "dossierUrl": "https://glp1dossier.com/is-ro-legit",
      "providerUrl": "https://ro.co/weight-loss/",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy pill",
        "Wegovy pen",
        "Zepbound pen",
        "Zepbound KwikPen",
        "Ozempic",
        "Foundayo (orforglipron)"
      ],
      "oralOffered": true,
      "priceFromUsd": 74,
      "promoPriceUsd": 39,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$39 first month (refundable if ineligible), then $74/month on the 12-month prepaid plan up to $149/month; medication separate",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating B with 645 complaints in the three-year window, with recurring themes of surprise charges above the quoted price and unauthorized billing.",
          "source": "https://www.bbb.org/us/ny/new-york/profile/telemedicine/ro-0121-173581",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Ro exited compounded GLP-1s and its current catalogue is entirely FDA-approved product. Dose-tiered pricing means the 'from' price holds only at starting doses; Zepbound moves $299 to $449 on titration."
    },
    {
      "id": "roenrx",
      "name": "RoenRx",
      "dossierUrl": "https://glp1dossier.com/is-roenrx-legit",
      "providerUrl": "https://roenrx.com/prescriptions/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Ozempic",
        "Wegovy",
        "Zepbound",
        "Mounjaro"
      ],
      "oralOffered": false,
      "priceFromUsd": 135,
      "promoPriceUsd": 39,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; the cash rate of as low as $151/month for semaglutide applies when purchased quarterly",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Roen Health, Inc. dba RoenRx alleging it misbranded compounded semaglutide by displaying \"RoenRx\" on labels of a drug it did not compound, and by stating that \"Semaglutide is the active ingredient in FDA-approved medications like Wegovy and Ozempic\", which the agency said implies FDA approval the compounded product lacks.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/roen-health-inc-dba-roenrx-728293-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Advertises both an insurance route for branded GLP-1s and a cash route with a $39 first month. Includes 24/7 provider messaging at no extra cost."
    },
    {
      "id": "rxspan-md",
      "name": "RxSpan MD",
      "dossierUrl": "https://glp1dossier.com/is-rxspan-md-legit",
      "providerUrl": "https://www.rxspanmd.com/main-weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide + B12 (injectable & oral capsules)",
        "Compounded semaglutide ODT",
        "Compounded tirzepatide + B12 (injectable & oral capsules)",
        "Compounded tirzepatide ODT",
        "GLP Squared (dual GLP-1/GIP)",
        "Ozempic",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 249,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Strive Pharmacy",
        "Epiq Scripts",
        "Belmar Pharmacy",
        "Casa Pharma Rx"
      ],
      "membershipFee": "No separate membership fee; month-to-month compounded semaglutide injection or oral capsules are $249/mo ($219/mo on 3-mo prepay, $199/mo on 6-mo, $194/mo on 12-mo injection [$2,327] or $179/mo on 12-mo oral capsules [$2,148]); semaglutide ODT and GLP Squared start at $179/mo; compounded tirzepatide injection is $329/mo ($309/mo 3-mo, $289/mo 6-mo, $269/mo 12-mo [$3,228]) and tirzepatide ODT is $199/mo",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "RxSpan MD (rxspanmd.com/main-weight-loss) offers compounded semaglutide and tirzepatide (injections, oral capsules, sublingual Semaglutide ODT, and GLP Squared) at $249/month month-to-month ($179/month first-month promo or 12-month oral capsule prepay; $199/month 12-month Semaglutide ODT; $219/month 12-month GLP Squared). Clinical care is provided by Lion MD (Dr. Ana Lisa Carr, MD; Dr. Kelly Tenbrink, MD), dispensing through Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx."
    },
    {
      "id": "sesame",
      "name": "Sesame Care",
      "dossierUrl": "https://glp1dossier.com/is-sesame-legit",
      "providerUrl": "https://sesamecare.com/service/online-weight-loss-program",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy pill",
        "Wegovy pen",
        "Zepbound",
        "Ozempic",
        "Mounjaro",
        "Foundayo",
        "Rybelsus",
        "Saxenda"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": 59,
      "medicationIncluded": false,
      "feeStructure": "pay_per_visit",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "Read on 1 Nov 2026 from sesamecare.com/service/online-weight-loss-program: the Success by Sesame weight-loss program is $99/month month to month, with savings of $60 every 3 months ($79/mo), $180 every 6 months ($69/mo) or $480 a year on the annual plan ($59/mo); video visits, labs and messaging are included, medication is not (brand-name GLP-1 options from $149/month without insurance)",
      "insurance": "both",
      "intake": "Live video telehealth consultation with a patient-selected licensed clinician on the Sesame marketplace; includes Quest Diagnostics metabolic lab work in 41 states (excluding AZ, HI, ND, NJ, NY, OK, RI, SD, and WY)",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-01",
      "note": "Sesame Care (sesamecare.com/service/online-weight-loss-program; operated by Sesame, Inc.) operates both a direct-pay marketplace of independent licensed clinicians (standalone visits from $34) and the dedicated Success by Sesame clinical weight-loss subscription ($99/month month to month as read on 1 Nov 2026, $79/month on 3 months, $69/month on 6 months, down to $59/month on an annual commitment, with discounted rates for Costco members). Success by Sesame includes live video physician consultations, unlimited provider messaging, insurance prior-authorization support, and Quest Diagnostics metabolic lab work (included in all states except AZ, HI, ND, NJ, NY, OK, RI, SD, and WY). Named LillyDirect telehealth partner; clinicians on Sesame prescribe FDA-approved medications only—Wegovy pens and oral tablets, Zepbound vials and pens, Ozempic, Mounjaro, oral Foundayo (orforglipron, from $149/month self-pay), Saxenda, and Rybelsus—and do not prescribe compounded GLP-1s or controlled weight-loss substances. Full subscription refunds are issued if cancelled at least 3 hours before the initial video visit. No FDA warning letter or federal enforcement action naming Sesame, Inc. was found on record."
    },
    {
      "id": "shed",
      "name": "Shed",
      "dossierUrl": "https://glp1dossier.com/is-shed-legit",
      "providerUrl": "https://www.tryshed.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 199,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee advertised, but the terms set a minimum term: subscriptions are only eligible for cancellation after two months or at the close of your renewal cycles, whichever is longer.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Shed Holdings, LLC of South Jordan, Utah. Compounded semaglutide injections start at $199 a month on its weight-loss page (read 11 Nov 2026); for compounded tirzepatide the site gives two starting prices, “as low as $239/mo” on its homepage and “starting at $299/month” on its weight-loss page. Wegovy and Zepbound appear on the site but are referred out to LillyDirect and NovoCare rather than supplied by Shed, which is why this is recorded as a compounded provider. The cancellation clause is the single most consequential term and it lives in the terms of service rather than on the pricing page."
    },
    {
      "id": "skinnyrx",
      "name": "SkinnyRx",
      "dossierUrl": "https://glp1dossier.com/is-skinnyrx-legit",
      "providerUrl": "https://skinnyrx.com",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide (injectable & sublingual)",
        "Compounded tirzepatide (injectable & sublingual)",
        "Wegovy",
        "Foundayo"
      ],
      "oralOffered": true,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": null,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": null,
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Lean Rx, Inc. dba SkinnyRx alleging it misbranded compounded semaglutide and tirzepatide by displaying \"SkinnyRx\" on the pictured labels, suggesting SkinnyRx was the compounder when it was not, and by website statements including \"Get access to the same active ingredient as name-brand GLP-1 medications\" and \"It contains the same active ingredient as FDA-approved medications\", which the agency said imply FDA approval the compounded products do not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-rx-inc-dba-skinnyrx-717989-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "SkinnyRx (skinnyrx.com; SkinnyRx LLC per skinnyrx.com/terms) offers compounded semaglutide and tirzepatide injections, sublingual oral drops, and tablets starting at $199/month ($299/month ongoing depending on formulation and dose). Auto-renewing subscription model fulfilled through partner 503A compounding pharmacies; prescriptions are final once transmitted to the pharmacy."
    },
    {
      "id": "snagrx",
      "name": "SnagRx",
      "dossierUrl": "https://glp1dossier.com/is-snagrx-legit",
      "providerUrl": "https://snagrx.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide injection",
        "Compounded tirzepatide injection"
      ],
      "oralOffered": false,
      "priceFromUsd": 69,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Precision Compounding Pharmacy",
        "HealthWarehouse",
        "Triad Rx"
      ],
      "membershipFee": "States no membership fees and no hidden costs; the monthly price is advertised as covering medication, supplies, the telemedicine visit, physician review and shipping, with the rate locked in and cancellation at any time.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Run by Modern Metabolic Medicine, Inc. — the same legal entity behind Embody, with clinical care through OpenLoop Health and fulfillment through partner pharmacies Red Rock Compounding Pharmacy (St. George, UT), HealthWarehouse (Florence, KY), Precision Medicine / Precision Compounding Pharmacy (Bellmore, NY), and Triad Rx (Daphne, AL). During its Pre-Black Friday sale (read 11 Nov 2026) compounded semaglutide is $69/month and tirzepatide $119/month, presented as locked-in flat pricing for life against struck-through prices of $299 and $349."
    },
    {
      "id": "sprout-health",
      "name": "Sprout Health",
      "dossierUrl": "https://glp1dossier.com/is-sprout-health-legit",
      "providerUrl": "https://joinsprouthealth.com/join-glp1-org/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 149,
      "promoPriceUsd": 99,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; compounded semaglutide is $149/4 weeks month-to-month, $125/4 weeks on a 3-month plan ($375 every 12 weeks), $110/4 weeks on a 6-month plan ($660 every 26 weeks), or $99/month on a 12-month plan ($1,188 billed annually); compounded tirzepatide starts at $149/month on the 12-month plan",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Sprout Health Partners LLC alleging its compounded semaglutide and tirzepatide marketing was false or misleading — citing the claim that \"GLP-1 medications are FDA-approved and backed by extensive clinical research\" — making the products misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sprout-health-partners-llc-dba-sprout-health-715879-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Sprout Health (joinsprouthealth.com / go.joinsprouthealth.com; operated by Sprout Health Partners LLC) offers flat-dose compounded semaglutide ($149 per 4 weeks month-to-month or $99/month billed $1,188 annually on a 12-month plan) and compounded tirzepatide (from $149/month on a 12-month plan), while listing branded Wegovy and Zepbound from $1,799 and $1,999. Does not bill insurance."
    },
    {
      "id": "strut-health",
      "name": "Strut Health",
      "dossierUrl": "https://glp1dossier.com/is-strut-health-legit",
      "providerUrl": "https://struthealth.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "compounded oral semaglutide",
        "compounded injectable semaglutide",
        "compounded oral tirzepatide",
        "compounded injectable tirzepatide"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Read on 14 Nov 2026 from struthealth.com: compounded oral semaglutide (buccal lozenge) $99 per 30-day supply on auto-refill, compounded semaglutide injectable $129 per monthly vial on auto-refill, and compounded tirzepatide injectable from $149 per monthly vial (price depends on the prescribed dose); the pages do not state a separate membership fee",
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Strut Health, LLC dba Strut (MARCS-CMS 721448).",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-14",
      "note": "Strut Health (struthealth.com; Strut Health, LLC per struthealth.com/terms-and-conditions) offers compounded semaglutide (oral buccal lozenge $99 per 30-day supply and injectable $129 per monthly vial as read on 14 Nov 2026) and compounded tirzepatide (injectable from $149 per monthly vial, dose-dependent) all-in with asynchronous physician consultation and shipping included. Dispensed by partner US 503A compounding pharmacies."
    },
    {
      "id": "teladoc",
      "name": "Teladoc Health",
      "dossierUrl": "https://glp1dossier.com/is-teladoc-legit",
      "providerUrl": "https://www.teladochealth.com/individuals/glp-1",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": false,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "accepts",
      "intake": null,
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "single",
      "priceCheckedAt": "2026-11-16",
      "note": "Teladoc does not state whether it supplies branded or compounded product; branded is an assumption from the page, not an assertion by the company. No price is published and a 'discounted self-pay option' is referenced without a figure. Access generally requires an insurer, employer or plan sponsor to offer the program, so it is not really a direct-to-consumer cash purchase and does not belong in a cash-price comparison table."
    },
    {
      "id": "telos-rx",
      "name": "telos rx",
      "dossierUrl": "https://glp1dossier.com/is-telos-rx-legit",
      "providerUrl": "https://telosrx.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide",
        "Compounded tirzepatide",
        "Microdosed tirzepatide",
        "Oral tirzepatide"
      ],
      "oralOffered": true,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee. The company states the rate stays the same as the dose is titrated, so the bill does not climb with the dose. Does not bill insurance; FSA and HSA eligible.",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Superior Health Solutions LLC. Semaglutide from $99 a month, microdosed tirzepatide from $116, oral tirzepatide from $129, injectable tirzepatide from $139 — every figure phrased as \"as low as\". Worth knowing where those numbers come from: the pricing section of the company's own homepage does not render, and the figures are readable only on its comparison pages."
    },
    {
      "id": "thrive-health-solutions",
      "name": "Thrive Health Solutions",
      "dossierUrl": "https://glp1dossier.com/is-thrive-health-solutions-legit",
      "providerUrl": "https://thrivecolorado.com/services/weight-loss-clinic-in-denver/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Thrive ULTRALean (Semaglutide)",
        "Thrive MEGALean (Tirzepatide)"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": null,
      "insurance": "cash",
      "intake": null,
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Thrive Health and Wellness, LLC dba Thrive Health Solutions alleging its sterile drug products, including NAD+ injection and MEGALean tirzepatide injections, were prepared, packed or held under insanitary conditions — citing aseptic operations conducted outside a certified ISO 5 area, personnel who had never performed media fills, non-sterile gloves with exposed hair and skin, carpeted flooring and failure to use a sporicidal agent — and that the products are unapproved new drugs and misbranded for lacking adequate directions for use.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrive-health-and-wellness-llc-dba-thrive-health-solutions-714891-02092026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "A Denver-area medical spa that also sells GLP-1s online, branding compounded semaglutide as ULTRALean and tirzepatide as MEGALean. No dollar prices are published on its public site. Unlike the marketing letters in the other batches, this one concerns manufacturing conditions."
    },
    {
      "id": "thrivelab",
      "name": "Thrivelab",
      "dossierUrl": "https://glp1dossier.com/is-thrivelab-legit",
      "providerUrl": "https://www.thrivelab.com/weight-loss",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Oral Semaglutide"
      ],
      "oralOffered": true,
      "priceFromUsd": 175,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$45 initial appointment with a licensed provider, and $45 for an intro dietitian appointment",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Thrivelab Co. dba Thrivelab alleging its website labelling identified \"thrivelab\" on pictured compounded semaglutide labels, suggesting Thrivelab was the compounder when it was not, and that claims such as \"Same active ingredient as Wegovy and Ozempic\" and \"clinically proven to work\" represented the compounded product as FDA-approved or evaluated for safety and effectiveness.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrivelab-co-dba-thrivelab-728294-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "The $175/month rate is a promotional intro price; following months are listed at $175-$250 and the semaglutide page shows a regular rate of $350/month. Insurance is used for the telehealth visits rather than the medication."
    },
    {
      "id": "tmates",
      "name": "TMates",
      "dossierUrl": "https://glp1dossier.com/is-tmates-legit",
      "providerUrl": "https://tmates.com/products",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide (injectable & oral)",
        "Compounded tirzepatide (injectable & oral)",
        "Wegovy",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 249,
      "promoPriceUsd": 158,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee on compounded plans (all-inclusive month-to-month or 3-, 6- and 12-month prepaid tiers); $99/month consultation plan for branded Wegovy or Zepbound prescriptions (branded medication paid separately at pharmacy)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "TMates (tmates.com/products) offers all-in compounded semaglutide at $249/month month-to-month ($158/month on 12-month prepay, $1,896 upfront) and compounded tirzepatide at $297/month ($167/month on 12-month prepay, $2,004 upfront), plus a $99/month Rx-only plan for branded Wegovy or Zepbound (drug cost separate). Refunds apply only before prescription dispatch; multi-month cancellations convert used months to the non-discounted monthly rate."
    },
    {
      "id": "trimi",
      "name": "Trimi",
      "dossierUrl": "https://glp1dossier.com/is-trimi-legit",
      "providerUrl": "https://trytrimi.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 99,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; month-to-month is $175/month for compounded semaglutide and $235/month for compounded tirzepatide across all doses; advertised $99/month (semaglutide) and $125/month (tirzepatide) rates require a 12-month upfront prepayment ($1,188 or $1,500 billed annually)",
      "insurance": "Cash-pay only (HSA/FSA accepted)",
      "intake": "Asynchronous online medical questionnaire reviewed by licensed clinicians within 24 hours",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Operated by TRYTRIMI LLC d/b/a Trimi Health (trytrimi.com/terms-of-service). Offers flat-dose pricing across all titration tiers for compounded semaglutide ($175/month month-to-month, $145/month quarterly, $115/month semi-annual, or $99/month billed annually at $1,188) and compounded tirzepatide ($235/month month-to-month, $185/month quarterly, $155/month semi-annual, or $125/month billed annually at $1,500), fulfilled by partner 503A compounding pharmacies with overnight shipping. Per Trimi's Terms of Service, all prescription sales are final once issued by a clinician. No FDA warning letter or federal enforcement action naming TRYTRIMI LLC was found on record."
    },
    {
      "id": "trimrx",
      "name": "TrimRx",
      "dossierUrl": "https://glp1dossier.com/is-trimrx-legit",
      "providerUrl": "https://trimrx.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide (GLP-1)",
        "Compounded tirzepatide (GLP-1 + GIP)",
        "Ozempic",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 299,
      "promoPriceUsd": 179,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; per Section 14 of TrimRx’s Terms and Conditions, GLP-1 (compounded semaglutide) is $199 for the first month then $299/month ongoing (or from $179/mo on annual prepaid bundles); GLP-1 + GIP (compounded tirzepatide) is $349 first month then $399/month ongoing; branded Ozempic is $1,299/month and Zepbound is $1,399/month",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "BBB rating F, not accredited, with a Pattern of Complaints alert, 728 complaints receiving no response and 221 unresolved; BBB states consumers allege charges before medical approval, charges different from the amount selected, ignored cancellation requests and undisclosed fees.",
          "source": "https://www.bbb.org/us/ca/san-diego/profile/weight-loss/trimrx-1126-1000142532",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "TrimRx (trimrx.com; TrimX) offers compounded semaglutide ($179 first month, $249/month ongoing) and compounded tirzepatide ($269 first month, $349/month ongoing), plus oral GLP-1 formulations. Per trimrx.com/terms-and-conditions, TrimRx is a telehealth technology platform coordinating independent physician groups and state-licensed 503A compounding pharmacies; subscriptions auto-renew and dispensed medications are non-refundable."
    },
    {
      "id": "trym-health",
      "name": "TRYM Health",
      "dossierUrl": "https://glp1dossier.com/is-trym-health-legit",
      "providerUrl": "https://trymhealth.com/pricing/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide",
        "Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 95.83,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "States zero membership fees and no shipping costs; semaglutide is $150 month to month, $375 per 12 weeks, $650 per 24 weeks or $1,150 for 12 months (about $95.83/mo); tirzepatide is $180 month to month up to $1,500 for 12 months (read 11 Nov 2026)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to TRYM Health, Inc. alleging website claims including \"Clinically Proven to Work\", \"Contains the same active ingredient as Mounjaro and ZepBound\" and \"Contains the same active ingredient as Ozempic and Wegovy\" implied its compounded products were the same as FDA-approved drugs, making them misbranded.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trym-health-inc-dba-trym-health-716699-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only; the site now displays a notice that compounded drugs are not FDA-approved, though its FAQ still says its compounded medications use the same main active ingredients as branded medications. Explicitly accepts no insurance."
    },
    {
      "id": "tuyo-health",
      "name": "Tuyo Health",
      "dossierUrl": "https://glp1dossier.com/is-tuyo-health-legit",
      "providerUrl": "https://www.tuyohealth.com/weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Wegovy",
        "Zepbound",
        "Metformin"
      ],
      "oralOffered": false,
      "priceFromUsd": 155,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "A $9.99/month or $119/year primary care membership is advertised; branded Wegovy and Zepbound carry a separate $99 membership fee",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Tuyo Health, Inc. alleging its compounded semaglutide and tirzepatide were misbranded because website claims such as \"Same active as Wegovy and Ozempic\" and \"Same active ingredient as Zepbound and Mounjaro\" implied equivalence to FDA-approved drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tuyo-health-inc-dba-tuyo-health-716502-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Compounded semaglutide from $155/mo and tirzepatide from $279/mo with no insurance needed; branded Wegovy and Zepbound advertised as low as $25/mo when paying with insurance, against $499 and $399 cash. Presents as a broader virtual primary care membership rather than a GLP-1-only brand."
    },
    {
      "id": "tyde-wellness",
      "name": "Tyde Wellness",
      "dossierUrl": "https://glp1dossier.com/is-tyde-wellness-legit",
      "providerUrl": "https://tydewellness.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide"
      ],
      "oralOffered": false,
      "priceFromUsd": 113,
      "promoPriceUsd": 88,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No separate membership fee; standard monthly compounded semaglutide is $249/month, while multi-month prepaid plans with $150 first-order discount bring starter pricing down to $88–$113/month equivalent for semaglutide and $125–$150/month equivalent for tirzepatide",
      "insurance": "Cash-pay only (HSA/FSA accepted)",
      "intake": "Asynchronous telehealth medical evaluation through Tyde Medical Center LLC",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-27",
      "note": "Operated by Tyde Wellness LLC with clinical care through Tyde Medical Center LLC (tydewellness.com). Offers compounded semaglutide ($249/month standard monthly rate, or from $88/month equivalent on discounted multi-month starter plans with $150 off first 3- or 6-month order) and compounded tirzepatide (from $125/month equivalent on discounted multi-month starter plans), fulfilled by partner 503A compounding pharmacies. No FDA warning letter or federal enforcement action naming Tyde Wellness LLC was found on record."
    },
    {
      "id": "villas-health",
      "name": "Villas Health",
      "dossierUrl": "https://glp1dossier.com/is-villas-health-legit",
      "providerUrl": "https://villashealth.com/weight-loss-programs/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded GLP-1",
        "GLP-1 Dissolvable Melts"
      ],
      "oralOffered": true,
      "priceFromUsd": 179,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "An optional membership at $19.99/month gives a 20% discount on every order",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Las Villas Health Care LLC dba Villas Health alleging its compounded semaglutide and compounded sildenafil were misbranded because claims that the semaglutide \"contains the same active ingredient as Ozempic and Wegovy\" and that the sildenafil was \"the active ingredient in Viagra\" with clinical proof for female sexual arousal disorder implied equivalence to FDA-approved drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/las-villas-health-care-llc-dba-villas-health-716504-09092025",
          "date": "2025-09",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Both GLP-1 products are advertised from $179 for the first month; the site sells monthly titration tiers and a three-month bundle but does not publish the recurring prices, so $179 is a first-month figure rather than a confirmed recurring rate. A small Coral Gables, Florida operation selling online rather than a national brand."
    },
    {
      "id": "viviomd",
      "name": "VivioMD",
      "dossierUrl": "https://glp1dossier.com/is-viviomd-legit",
      "providerUrl": "https://viviomd.com/women",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Semaglutide",
        "Tirzepatide",
        "Ozempic",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": null,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "unverified_or_paused",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Site says the programme is all-inclusive with no hidden fees or separate memberships, cancel anytime",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to VivioMD Group LLC alleging it misbranded compounded semaglutide and tirzepatide because the product labels pictured on its website identify \"VivioMD\" as the compounder when it is not, and that the products are unapproved new drugs.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viviomd-group-llc-dba-viviomd-728295-06082026",
          "date": "2026-06",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Prices are not published on public pages; the site routes visitors through an intake assessment to see them. Advertises flat pricing that does not rise with dose, and HSA/FSA eligibility."
    },
    {
      "id": "weightcare",
      "name": "WeightCare",
      "dossierUrl": "https://glp1dossier.com/is-weightcare-legit",
      "providerUrl": "https://joinweightcare.com",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Semaglutide Weight Loss Program",
        "Tirzepatide Weight Loss Program",
        "Tirzepatide Spray",
        "Semaglutide Microdosing",
        "Tirzepatide Microdosing"
      ],
      "oralOffered": false,
      "priceFromUsd": 215,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "The $215/mo rate requires prepaying six months; the 3-month plan is $249/mo and month-to-month is $399/mo",
      "insurance": "cash",
      "intake": "video",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Weightless Medical LLC dba WeightCare alleging it misbranded compounded semaglutide and tirzepatide, stating that the representations on its website that WeightCare is the compounder of these drug products are false or misleading, and that the misbranded products were introduced into interstate commerce.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/weightless-medical-llc-dba-weightcare-721478-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Still compounded-only, and the site now carries the disclaimer that compounded semaglutide is not FDA-approved and that FDA does not evaluate compounded products for safety, effectiveness or quality. Plans include a same-day telehealth visit."
    },
    {
      "id": "weightwatchers-clinic",
      "name": "WeightWatchers Clinic",
      "dossierUrl": "https://glp1dossier.com/is-weightwatchers-clinic-legit",
      "providerUrl": "https://www.weightwatchers.com/us/clinic",
      "supplies": "branded",
      "compoundingStatus": "branded_only",
      "drugs": [
        "Wegovy",
        "Zepbound",
        "Saxenda",
        "metformin",
        "naltrexone/bupropion"
      ],
      "oralOffered": false,
      "priceFromUsd": 74,
      "promoPriceUsd": 25,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "$25 first month then $74/month on the 12-month plan or $84/month on the 6-month plan; GLP-1 medication excluded",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Formerly Sequence. Non-GLP-1 medications are included when filled through mail-order partner Carepoint. A named LillyDirect telehealth partner. WW International filed Chapter 11 in May 2025 to eliminate about $1.15bn of debt and the clinic continues to operate; that is a corporate-stability fact, not a consumer-harm finding (https://www.washingtonpost.com/business/2025/05/07/weight-watchers-bankruptcy-chapter-11-debt/)."
    },
    {
      "id": "wellmedr",
      "name": "Wellmedr",
      "dossierUrl": "https://glp1dossier.com/is-wellmedr-legit",
      "providerUrl": "https://www.wellmedr.com/pages/get-started-weight-loss",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded Semaglutide",
        "Compounded Tirzepatide",
        "Ozempic",
        "Zepbound"
      ],
      "oralOffered": false,
      "priceFromUsd": 41,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Logos Pharmacy",
        "Emerald Compounding Pharmacy",
        "Center City Pharmacy"
      ],
      "membershipFee": "No separate monthly membership fee on all-in plans; compounded semaglutide is advertised starting at $41/month ($191/month before the $150-off new-customer offer) and compounded tirzepatide starting at $71/month ($221/month before the $150-off offer) at flat pricing across all doses, while month-to-month branded Ozempic starts at $1,399/month and Zepbound at $1,599/month. Per Wellmedr’s Refund & Cancellation Policy, plans are billed either on a recurring 21-Day Plan (every 21 calendar days, up to 18 charges per 365 days) or as prepaid 3-, 6-, or 12-Month Plans where advertised per-month figures reflect the total prepaid price divided by the number of months Confirmed still advertised on 7 Nov 2026 at wellmedr.com/pages/get-started-weight-loss: Pre-Black Friday “$41/mo Semaglutide · $71/mo Tirzepatide” with a “$150 off for Life” new-customer lock-in.",
      "insurance": "cash",
      "intake": "Asynchronous online medical evaluation reviewed by independent U.S.-licensed clinicians (live visit or laboratory testing required where clinically or state-mandated)",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-10-28",
      "note": "Wellmedr (wellmedr.com/pages/get-started-weight-loss; operated by Wellmedr LLC, 7901 4th Street North, Suite 300, St. Petersburg, FL 33702, branded on-site as welludr. and WellMeDr per wellmedr.com/pages/terms-conditions, LegitScript certified) offers all-in flat-dose compounded semaglutide (advertised from $41/month with the $150-off new-customer offer, against a $191/month base equivalent) and compounded tirzepatide (from $71/month with the $150-off offer, against a $221/month base equivalent), alongside month-to-month branded Ozempic ($1,399/month) and Zepbound ($1,599/month), plus NAD+, Vitamin B12, and Sermorelin consultations. Per Wellmedr’s Terms & Conditions (updated October 16, 2026) and GLP-1 Medication Safety Information disclosure, prescriptions are evaluated by independent licensed clinicians and fulfilled by four named 503A partner pharmacies: Tradeline SH, Inc. d/b/a Logos Pharmacy, Emerald Compounding Pharmacy, Center City Pharmacy, and Red Rock Home Pharmacy (Red Rock Pharmacy). Per Wellmedr’s Refund & Cancellation Policy, entry recurring plans renew every 21 calendar days (up to 18 billing cycles per year) while 3-, 6-, and 12-month plans are prepaid upfront; a 100% refund is issued within 7 business days if a clinician does not approve treatment or if cancelled before the dispensing pharmacy begins Medication Fulfillment Start. Compounded medications are prepared by state-licensed 503A pharmacies and are not FDA-approved. No FDA warning letter or federal enforcement action naming Wellmedr LLC was found on record."
    },
    {
      "id": "wellorithm",
      "name": "Wellorithm",
      "dossierUrl": "https://glp1dossier.com/is-wellorithm-legit",
      "providerUrl": "https://wellorithm.com/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "Compounded semaglutide injection",
        "Oral dissolving GLP-1 tablets",
        "Ozempic",
        "Wegovy",
        "Mounjaro",
        "Zepbound"
      ],
      "oralOffered": true,
      "priceFromUsd": 247,
      "promoPriceUsd": 147,
      "medicationIncluded": null,
      "feeStructure": "unspecified",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "Read on 30 Oct 2026 from Wellorithm's campaign page (wellorithm.com/campaign-7): compounded semaglutide at a regular $247/month with $100 off the first month ($147), and tirzepatide at a regular $349/month with $100 off the first month ($249). Whether a separate membership fee applies is not stated on that page",
      "insurance": "both",
      "intake": "video",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "One of the few providers on this record offering all four branded products alongside compounded semaglutide and an oral dissolving tablet. It publishes no prices at all: the site claims transparent pricing while carrying no dollar figure anywhere, answering only that pricing varies based on the individual plan and services selected. No legal entity is named on the site."
    },
    {
      "id": "willow",
      "name": "Willow",
      "dossierUrl": "https://glp1dossier.com/is-willow-legit",
      "providerUrl": "https://www.startwillow.com/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide sublingual tablet (daily oral GLP-1)",
        "Compounded semaglutide injection (weekly)",
        "Compounded tirzepatide sublingual tablet (daily oral dissolving)",
        "Compounded tirzepatide injection (weekly)"
      ],
      "oralOffered": true,
      "priceFromUsd": 299,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [
        "Red Rock Pharmacy",
        "Empower Pharmacy",
        "Epiq Scripts",
        "The Pharmacy Hub",
        "AbsoluteRx"
      ],
      "membershipFee": "No monthly membership fee ($0); $299/month all-in for compounded semaglutide sublingual tablets or injections, and $399/month all-in for compounded tirzepatide oral dissolving tablets or injections (includes physician consultation and free 2-day shipping)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 3,
      "regulatoryActions": [
        {
          "what": "The National Advertising Division, on a challenge by Novo Nordisk, recommended on 4 December 2025 that Willow Health Services discontinue or modify health claims for its compounded semaglutide products. Willow declined to provide a compliance statement, and NAD referred the matter to regulatory authorities and to the platforms carrying the advertising.",
          "source": "https://bbbprograms.org/media/newsroom/decisions/willow-health",
          "date": "2025-12",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Reopened NAD matter closed after Willow Health Services voluntarily discontinued claims that its compounded semaglutide was proven to support weight loss, delivered results comparable to FDA-approved semaglutide, and produced effective weight loss without diet or exercise.",
          "source": "https://bbbprograms.org/media/newsroom/decisions/willow-health-ro",
          "date": "2026-07",
          "category": "regulatory_action",
          "sourceType": "primary"
        },
        {
          "what": "Eli Lilly sued Willow Health Services, Inc. in the Central District of California on 23 April 2025 (No. 2:25-cv-03570) over compounded tirzepatide. The case was dismissed with prejudice on 3 February 2026 for failure to establish Lanham Act standing — the court held the prescribing physician, not Willow's advertising, was the proximate cause of any lost sales — with no ruling on whether the marketing was misleading. Lilly has appealed to the Ninth Circuit (No. 26-1317).",
          "source": "https://storage.courtlistener.com/recap/gov.uscourts.cacd.967379/gov.uscourts.cacd.967379.71.0.pdf",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 2,
      "otherSignals": [
        {
          "what": "BBB profile for 'Start Willow' (Austin TX) rating D, not accredited, with 5 complaints of which 1 unanswered.",
          "source": "https://www.bbb.org/us/tx/austin/profile/weight-reduction-physician/start-willow-0825-1000237748",
          "date": null,
          "category": "other_signal",
          "sourceType": "secondary"
        },
        {
          "what": "Willow Health Services, Inc.'s Terms of Service (updated 14 August 2026) disclose six partner compounding pharmacies fulfilling startwillow.com prescriptions: Red Rock Home Pharmacy (Springville, UT), Red Rock Pharmacy (St. George, UT), Epiq Pharmacy / Epiq Scripts LLC (Richardson, TX), Absolute Pharmacy (Lutz, FL), The Pharmacy Hub (Miami, FL), and Empower Pharmacy (Houston, TX).",
          "source": "https://www.startwillow.com/terms-of-service",
          "date": "2026-08",
          "category": "other_signal",
          "sourceType": "primary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Willow Health Services, Inc. (startwillow.com and shop.startwillow.com; 8080 Westpark Drive, Suite 42292, Houston, TX 77063), with physician consultations provided through Willow Medical of California, P.C. (per startwillow.com/terms-of-service updated August 14, 2026 and startwillow.com/informed-consent). Supplies daily compounded GLP-1 sublingual tablets ($299/month for oral semaglutide tablets, $399/month for oral dissolving tirzepatide tablets) as well as weekly injections; these compounded oral GLP-1 tablets are prepared by state-licensed compounding pharmacies (Red Rock Home Pharmacy, Red Rock Pharmacy, Epiq Pharmacy, Absolute Pharmacy, The Pharmacy Hub, and Empower Pharmacy) rather than being FDA-approved oral semaglutide (Rybelsus or Wegovy pill). Cash-pay with HSA/FSA accepted; patients with type 1 or type 2 diabetes are excluded per the official FAQ. Cancellation must be requested at least 2 business days before the next processing date for a full refund in 5–10 business days if the prescription has not yet been sent to the pharmacy."
    },
    {
      "id": "yucca-health",
      "name": "Yucca Health",
      "dossierUrl": "https://glp1dossier.com/is-yucca-health-legit",
      "providerUrl": "https://tryyucca.com/treatments/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "Compounded semaglutide + Vitamin B12",
        "Compounded tirzepatide + Vitamin B12"
      ],
      "oralOffered": false,
      "priceFromUsd": 69,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "yes",
      "requiresMultiMonthPrepay": true,
      "disclosedPharmacies": [],
      "membershipFee": "No membership fee; Personalized Semaglutide + B12 is $89/month billed monthly, $75/month on a 6-month plan ($450 upfront), or $69/month on a 12-month plan ($828 upfront); Personalized Tirzepatide + B12 is $139/month billed monthly, $125/month on a 6-month plan ($750 upfront), or $119/month on a 12-month plan ($1,428 upfront)",
      "insurance": "cash",
      "intake": "async",
      "regulatoryActionsCount": 0,
      "regulatoryActions": [],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Yucca Health (tryyucca.com/treatments/; operated by Brand Merchants Network LLC d/b/a Yucca Health) offers Personalized Semaglutide + B12 at $89/month month-to-month ($69/month on 12-month upfront plan) and Personalized Tirzepatide + B12 at $139/month month-to-month ($119/month on 12-month upfront plan). Flat pricing across all dose tiers with no separate membership fee; non-refundable once assigned to a partner 503A compounding pharmacy."
    },
    {
      "id": "zealthy",
      "name": "Zealthy",
      "dossierUrl": "https://glp1dossier.com/is-zealthy-legit",
      "providerUrl": "https://try.getzealthy.com/zealthy-weight-loss-pricing/",
      "supplies": "both",
      "compoundingStatus": "mixed_compounded_and_branded",
      "drugs": [
        "compounded semaglutide",
        "compounded tirzepatide",
        "branded GLP-1s subject to insurance coverage"
      ],
      "oralOffered": false,
      "priceFromUsd": 135,
      "promoPriceUsd": 49,
      "medicationIncluded": false,
      "feeStructure": "membership_plus_medication",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "$135/month membership, discounted to $49 for the first month; $39 initial consultation; medication separate; cancel anytime",
      "insurance": "both",
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "In United States v. Cerebral, Inc., Zealthy, Inc., Gronk, Inc., and Kyle Robertson (S.D. Fla. Case No. 1:24-cv-21376), the Department of Justice and Federal Trade Commission filed a First Amended Complaint naming Zealthy, Inc. and its founder Kyle Robertson alongside Cerebral, alleging deceptive subscription enrollment, hidden medication charges on top of membership fees, and obstructive cancellation practices across Zealthy’s weight-loss and telehealth programs; DOJ subsequently moved for an immediate asset freeze and temporary receivership against Zealthy.",
          "source": "https://www.courtlistener.com/docket/68432608/united-states-v-cerebral-inc/",
          "date": "2024-11",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 1,
      "otherSignals": [
        {
          "what": "Industry reporting on DOJ’s August 2025 motion in S.D. Fla. seeking an immediate asset freeze and receivership over Zealthy, Inc. following allegations of continued deceptive billing and cancellation practices in its GLP-1 weight-loss program.",
          "source": "https://www.fiercehealthcare.com/health-tech/doj-seeks-immediate-asset-freeze-receivership-against-telehealth-company-zealthy",
          "date": "2025-08",
          "category": "other_signal",
          "sourceType": "secondary"
        }
      ],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Operated by Zealthy, Inc. (getzealthy.com; also searched by consumers as Zelphie), founded by former Cerebral CEO Kyle Robertson. Charges a $135/month coaching membership ($39 first month) with medication billed separately on top: compounded semaglutide starts at $151/month and compounded tirzepatide at $216/month on top of the membership fee. Named as a corporate defendant alongside Kyle Robertson in the FTC/DOJ federal enforcement action United States v. Cerebral, Inc., Zealthy, Inc., et al. (S.D. Fla. No. 1:24-cv-21376), in which the Department of Justice moved for a federal asset freeze and receivership."
    },
    {
      "id": "zeuss",
      "name": "Zeuss",
      "dossierUrl": "https://glp1dossier.com/is-zeuss-legit",
      "providerUrl": "https://getzeuss.com/services/body-for-him/",
      "supplies": "compounded",
      "compoundingStatus": "compounded_only",
      "drugs": [
        "GLP-1",
        "GIP/GLP-1"
      ],
      "oralOffered": false,
      "priceFromUsd": 125,
      "promoPriceUsd": null,
      "medicationIncluded": true,
      "feeStructure": "all_in",
      "samePriceEveryDose": "unspecified",
      "requiresMultiMonthPrepay": false,
      "disclosedPharmacies": [],
      "membershipFee": "No membership or subscription; the site states one-time purchase, no auto-renewals and no long-term commitments",
      "insurance": null,
      "intake": "async",
      "regulatoryActionsCount": 1,
      "regulatoryActions": [
        {
          "what": "FDA warning letter to Zeuss LLC alleging its compounded tirzepatide was misbranded because the label bore the Zeuss name, representing it as the compounder when it was not, and because website statements including \"It is FDA approved and clinically proven to work treatment for weight loss\" implied FDA approval the compounded product does not have.",
          "source": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zeuss-llc-dba-zeuss-717985-02202026",
          "date": "2026-02",
          "category": "regulatory_action",
          "sourceType": "primary"
        }
      ],
      "otherSignalsCount": 0,
      "otherSignals": [],
      "confidence": "verified",
      "priceCheckedAt": "2026-11-16",
      "note": "Zeuss no longer names semaglutide or tirzepatide anywhere on its public pages, listing only the drug classes GLP-1 and GIP/GLP-1."
    }
  ]
}
